Examining Body Mass Index and Sepsis Mortality at One Year After Sepsis by Robinson, Jamie D
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2020 
Examining Body Mass Index and Sepsis Mortality at One Year 
After Sepsis 
Jamie D. Robinson 
Virginia Commonwealth University 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Critical Care Nursing Commons, and the Public Health and Community Nursing Commons 
 
© The Author 
Downloaded from 
https://scholarscompass.vcu.edu/etd/6262 
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It 
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars 
Compass. For more information, please contact libcompass@vcu.edu. 
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2020 
Examining Body Mass Index and Sepsis Mortality at One Year 
After Sepsis 
Jamie D. Robinson 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Critical Care Nursing Commons, and the Public Health and Community Nursing Commons 
 
© The Author 
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It 
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars 
Compass. For more information, please contact libcompass@vcu.edu. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©Jamie D. Robinson 2020 
All Rights Reserved 
  
 
 
EXAMINING BODY MASS INDEX AND MORTALITY AT ONE YEAR AFTER SEPSIS 
 
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University.  
 
by  
 
JAMIE D. ROBINSON 
 
Master of Science (Nursing), 
University of Virginia, 2007 
Bachelor of Science (Nursing),  
Shenandoah University, 2004 
Associate of Science (Nursing),  
Shenandoah University, 1998 
 
 
 
 
 
 
Advisor: Theresa Swift-Scanlan, Ph.D., RN, FAAN 
Ellen Fontaine Winston Distinguished Professor,  Director, Biobehavioral Laboratory Services, 
Associate Professor, Department of Adult Health and Nursing Systems 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Virginia Commonwealth University  
Richmond, Virginia  
April 2020 
.  
 
 
Acknowledgement 
I would like to thank Dr. Theresa Swift-Scanlan, my dissertation chair, for her mentoring 
and teaching, patience, and encouragement. Dr. Swift-Scanlan leveraged her vast experience and 
expertise in nursing research and provided tremendous insight and valuable perspectives that 
strengthened my project and augmented my professional development overall.  I would like to 
thank my committee members, Dr. R. K. Elswick, Dr. Jeanne Salyer, Dr. Terry Jones, and Dr. 
Maria deValpine.  The collective efforts from my committee and Dr. Swift-Scanlan was 
invaluable.  My committee constantly modeled professionalism --they encouraged curiosity 
through thoughtful questioning, gave excellent recommendations, and constantly encouraged and 
supported me in this process. I am extremely grateful for their diligence in seeing me through 
this journey. I am also very thankful for the support provided by the team of data analysts at the 
C. Kenneth and Dianne Wright Center for Clinical and Translational Research for their expertise 
in my journey through Big Data. 
  
 
i 
Table of Contents 
List of Tables ...................................................................................................................... ii 
List of Figures .................................................................................................................... iii 
Abstract ................................................................................................................................4 
Introductory Narrative  ........................................................................................................2 
Chapter 1: .............................................................................................................................3 
Obesity and One-Year Mortality in Adults After Sepsis: A Systematic Review  
(manuscript #1) 
 
Chapter 2: ...........................................................................................................................35 
The Obesity Paradox in Sepsis: A theoretical framework (manuscript #2) 
 
Chapter 3: ...........................................................................................................................65 
Project Proposal 
 
Chapter 4: ...........................................................................................................................94 
Examining Body Mass Index and Mortality at One Year after Sepsis (manuscript #3) 
 
Concluding Narrative .......................................................................................................133 
 
Vita ...................................................................................................................................135 
 
 
 
ii 
List of Tables 
Chapter One 
Literature Review Table .................................................................................. 29-36 
Chapter Four 
Descriptive Statistics of the Variables in the Study .............................................130 
Logistic Regression Modeling of the Variables in the Study .......................... 29-36 
 
 
 
iii 
List of Figures 
Chapter One 
Flow diagram of literature search and study selection ..................................... 11-12 
Chapter Two 
A hypothesized model of inflammatory modulation ....................................... 44-45 
A comparison of the normal response to infection and the dysregulation  
response in sepsis ...................................................................................................47 
Hypothesized relationship between obesity, sepsis, and sepsis mortality ....... 48-49 
Example of how to use the proposed model to test relationships ..........................50 
Chapter Three 
Hypothesized relationship between HPA dysregulation and obesity associated 
factors  .............................................................................................................. 71-72 
The normal immune response ................................................................................73 
Comparison of biomarker changes in normal versus dysregulated responses . 75-76 
Hypothesized relationship between obesity factors and sepsis mortality ..............77 
Variables included in this research .................................................................. 77-78 
Chapter Four 
Study Flow Diagram ............................................................................................126 
The interaction terms of sepsis type and BMI for 180 Day Mortality  ................127 
The interaction terms of sepsis type and BMI for 1 year Mortality ....................128
 
Abstract  
Introduction:  Sepsis is a serious and life-threatening syndrome affecting 1.7 million Americans 
annually and resulting in approximately 270,000 deaths.  An “obesity paradox” where obese 
individuals have lower sepsis mortality than their non-obese counterparts has been described.  
The problem is that the longevity of the effect is unknown, and few studies have examined the 
obesity paradox after 1-2 months post-diagnosis.   
 
Methods: This retrospective cohort study examined clinical, demographic, and biomarker 
variables thought to affect sepsis mortality at three-time points: 30 days, 180 days, and at one 
year post-sepsis diagnosis in order to shed light on specific factors that might define a “sepsis 
survivor” phenotype.  A convenience sample of adults age 18 and older admitted to an academic 
medical center between the years of 2007 to 2018 with a diagnosis of sepsis was identified.  
Simple logistic regression was used to test for significance between age, sex, race, c-reactive 
protein, lactate, white blood cells, body mass index, and sepsis severity on mortality at each of 
the three previously described time points.  Variables with statistical and clinical significance 
were entered into multivariate logistic regression models to explore the contributions of each 
variable and interactions between variables at 30 days, 180 days, and one year after sepsis 
diagnosis.   
 
Results:  We found for every 5 unit increase in BMI, the odds of mortality were 0.92 (95% CI: 
0.85, 0.99) times lower at 30 days since sepsis diagnosis.  However, at 180-day and one-year 
post sepsis diagnosis, as BMI increased, there was an increase in odds of death for each sepsis 
type.  
 
Discussion:  In this dataset, it appears that the "obesity paradox" exists up to 30 days, but the 
protective effect of obesity on sepsis outcomes may not extend beyond one month. Future studies 
that control for comorbidities and other potential covariates, and that can test for the 
contributions of novel biomarkers on sepsis outcomes are needed. 
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Introductory Narrative 
This dissertation represents a collection of scholarly work based on the preparation, 
implementation and analysis of a retrospective dataset that examined the association of body 
mass index on sepsis mortality at one year. This dissertation is formatted following the Virginia 
Commonwealth University School of Nursing’s Manuscript Dissertation Option, which differs 
from the traditional dissertation format. With the manuscript option, the dissertation has four 
chapters, each of which each is styled to the requirements of the associated grant or journal and 
is summarized with a conclusive narrative.  Chapter One is the literature review that describes 
the current state of the science of sepsis mortality in the context of obesity (Robinson, Swift-
Scanlan, & Salyer, 2020). Chapter Two describes the conceptual framework developed for use in 
this dissertation. This framework demonstrates the relationships between demographic and 
biological variables that impact sepsis mortality. (Robinson, Swift-Scanlan, Salyer, & Jones, 
2020). Chapter Three is the project proposal and includes the specific aims, significance of the 
study, research strategy and methods. Chapter Four is the results manuscript which is submission 
ready to the journal “Biological Research for Nursing” pending review of the committee 
members who are co-authors on this results paper. This introductory narrative that follows, along 
with the abstract and concluding narrative, together represent a comprehensive dissertation. 
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Chapter One 
Obesity and One-Year Mortality in Adults After Sepsis: A Systematic Review 
Jamie Robinson, Theresa Swift-Scanlan, Jeanne Salyer 
Virginia Commonwealth University 
Manuscript published in Biological Research for Nursing 
(January 2020) 
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Abstract 
Purpose:  In recent years researchers have noted an “obesity paradox,” where individuals with 
obesity survive sepsis at higher rates than their nonobese counterparts. This systematic review 
summarizes the literature on studies examining the association between obesity and 1-year 
mortality among patients admitted with sepsis, severe sepsis, or septic shock. 
Materials and methods: Using a comprehensive search strategy, a systematic review was 
conducted to identify studies examining the association of obesity and sepsis mortality. PubMed, 
Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Elton B. Stephens 
Company (EBSCO) host databases were searched for the terms sepsis, obesity, mortality, and 
adult.  
Results: The initial search identified 189 studies, 9 of which met inclusion criteria. Of these, 4 
provide evidence that obese or very obese patients with sepsis have lower mortality than 
nonobese patients. Methodologic differences in the remaining 5 studies that report conflicting 
results limit generalizability.  
Conclusion: This systematic review on the association of obesity and sepsis mortality revealed 3 
studies that demonstrate lower mortality among obese patients in the first 30 days, and one study 
that shows this protection extends up to 1 year.  The studies that showed inconsistent results 
were difficult to generalize due to methodological constraints. Given the increased number of 
patients surviving sepsis, it is important to consider long-term mortality and further describe the 
variables associated with increased survival. 
 Keywords: Obesity, Body Mass Index, Sepsis, Mortality 
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Obesity and One-Year Mortality in Adults After Sepsis: A Systematic Review 
Background 
Sepsis and obesity have high incidence and mortality rates independent of each other. 
When taken together, one might expect a perfect storm in which patient outcomes are 
exponentially worse than either diagnosis on its own.  This notion is countered by the “obesity 
paradox” where obese individuals with sepsis survive at higher rates than non-obese individuals 
in the short term (Abbate et al., 2016; Arabi et al., 2013; Meyer et al., 2018; Nguyen et al., 2016; 
Sakr et al., 2013; Wacharasint et al., 2013). 
Despite extensive research, optimizing sepsis outcomes remains challenging.  Grim 
statistics indicate the magnitude of sepsis in the United States (US) is far reaching, with more 
than 1.5 million cases and 250,000 deaths occurring annually, and an estimated one out of every 
three hospital deaths that occur are due to sepsis (Centers for Disease Control and Prevention 
[CDC], 2017).  Due to recent advances in early sepsis recognition and treatment more people 
survive the initial insult, yet many experience persistent residual symptoms of physical, 
psychological, cognitive, and functional frailty from sepsis associated tissue impairment, 
metabolic impairment, and organ dysfunction (Gardner et al., 2019; Winters et al., 2010).  
Subsequent increased utilization of healthcare, including hospital re-admission, has been 
reported along with increased late mortality (Iwashyna & Netzer, 2012; Yende, et al., 2016).  
Meanwhile the literature often examines mortality at 30, 60, or 90 days, omitting end points that 
may better estimate the long-term effects.  Given the “obesity paradox,” whereby obese patients 
survive inflammatory conditions at higher rates than non-obese patients, (Braun et al., 2017; De 
Schutter et al., 2016; Hafner, Hillenbrand, Knippschild, & Radermacher, 2013), it is important to 
explore the impact of obesity on long-term sepsis outcomes.  
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Obesity is a global epidemic associated with complex multi-system diseases affecting 
cardiovascular, endocrine, and mental health, and increased all-cause mortality (Keaver, Xu, 
Jaccard, & Webber, 2018).  Complications of obesity can potentiate each other, such as type 2 
diabetes and hypertension leading to chronic kidney disease, a potential cause of early disability.  
The physiologic consequences of obesity increase the risk for complications and likelihood of 
slowed recovery from sepsis.  However, taken together sepsis and obesity are associated with 
better rather than worse survival in the short term, observations that have collectively identified 
the “obesity paradox.” 
Inconsistent results on the impact of obesity on other critical illness have indicated that 
obesity may be related to better, worse, or unchanged rates of hospital and intensive care unit 
(ICU) length of stay and mortality (Martino et al., 2011).  A theme that many studies uncovered 
is that the consequences of critical illness continues for years after hospital discharge (Gardner et 
al., 2019; Winters et al., 2010).  For instance, examining data from the Health and Retirement 
Study (HRS) researchers found a significant increase in the odds of cognitive dysfunction and 
physical dysfunction that continued through an 8-year follow up period (Iwashyna, Ely, Smith, & 
Langa, 2010). Narrowing the scope of investigation from critical illness to sepsis will be pivotal 
in order to establish relationships among variables affecting mortality and to identify a 
phenotype of sepsis survivors.  Given the implications of obesity on sepsis mortality in the short 
term, and the resultant chronicity of sepsis following survival, the objective of this systematic 
review is to describe the association of obesity and one-year mortality in adults after sepsis. 
Methods 
Using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) 
guidelines (Liberati et al., 2009) PubMed, Cumulative Index of Nursing and Allied Health 
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Literature (CINAHL), and Elton B. Stephens Company (EBSCO) host were searched to access 
research published between the years 2013 to 2018 to identify relevant articles.  The review of 
the literature was conducted from November 2017 to May 2018 by the primary author.  Studies 
were included in the review if they were published in the English language between 2013 and 
2018 and reported mortality in subjects 18 years or older. This time period of 2013 to 2018 was 
chosen to reflect the current state of the literature. Each database was searched for the terms 
“sepsis,”  “obesity,” “mortality,” and “adult,” with the additional limiters listed above.  A total of 
189 studies were identified from databases and two from ancestry searches.  Publications were 
excluded from review if the study examined a disease other than sepsis or if the population 
included obstetric patients, children, or neonates because body mass index (BMI) is a poor 
correlate of adiposity in these populations.  After 29 duplicate articles were removed 158 articles 
were screened.  The initial screening eliminated 121 articles that focused on a different patient 
population or disease foci, including but not limited to post-operative, cancer, or pediatrics.  An 
additional 28 articles were eliminated after reading the title, full abstract, introduction, and 
methodology sections of the articles due to a disparate focus of research, to include dose 
response to mechanical ventilation, the association of BMI to gram positive bacteremia, and 
focus on properties of visceral adipose tissue.  The remaining 9 articles were read in their 
entirety and were included in this systematic review.  The search and screening results are 
reported in the figure.  
Figure 1: 
Flow diagram of literature search and study selection.  
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The methodological quality of all of the articles that met inclusion criteria were evaluated 
against the Strengthening the Reporting of Observational (STROBE) criteria (STROBE, 2009). 
These criteria outline elements that should be included in cohort studies investigating health 
outcomes.  A score of 1 was given for each criterion that was present in the articles, with the 
possible 0-22 score range, where 0 is methodologically unsound and 22 is the highest level of 
reporting.  The scoring of each publication is included in the literature review matrix (N =9, 
mean (M) = 20.88, Standard deviation (SD) = 0.60) calculated with Microsoft Excel for Mac 
version 16.16.2, see Table.  The topics identified for inclusion in the literature review matrix 
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included: (a) the first authors’ name and year of publication; (b) the research design and 
timeframe of the study; (c) sample and setting; (d) statistical analysis, and; (e) the main outcomes 
of the study. 
Results 
We included nine studies in the systematic review, all of which were retrospective cohort  
studies. To define obesity, four studies used the World Health Organization (WHO) criteria  
(WHO, 2016; Arabi et al., 2013; Gaulton et al., 2014; Kuperman et al., 2013; Papadimitriou 
Olivgeris et al., 2016), one of which collapsed the categories into “obese” for BMI < 30 kg/m2  
and “nonobese” for BMI < 30 kg/m2 (Papadimitriou-Olivgeris, 2016); two used the National  
Institutes of Health (NIH) criteria (NIH, n.d.; Gaulton et al., 2015; Wacharasint et al., 2013), one  
of which collapsed underweight and normal weight into a “< 25 kg/m2 BMI” category  
(Wacharasint et al., 2013); and three used binary Y/N based on International Classification of  
Diseases, 9th edition (ICD-9), coding (Abbate et al., 2016; (Nguyen, 2016; Prescott et al., 2014),  
one of which derived presence of obesity from Elixhauser comorbidity coding (Austin, Wong,  
Uzzo, Beck, & Egleston, 2015; Nguyen, 2016).  Studies also defined sepsis using several  
methods: two used the 1992 American College of Chest Physicians/Society of Critical Care  
Medicine Consensus definitions (ACCP/SCCM; Arabi et al., 2013; Wacharasint et al., 2013),  
one used the 2001 ACCP/SCCM Consensus definitions (Gaulton et al., 2015), four used ICD-9  
codes (Abbate et al., 2016; Kuperman et al., 2013; Nguyen et al., 2016; Prescott et al., 2014), one  
used diagnosis as the classification of sepsis (Papadimitriou-Olivgeris et al., 2016), and one used  
a presumed sepsis antibiotic algorithm (Gaulton et al., 2014). All of the studies examined  
mortality, with five reporting “in-hospital” mortality (Abbate et al., 2016; Arabi et al., 2013;  
Kuperman et al., 2013; Nguyen et al., 2016; Papadimitriou-Olivgeris et al., 2016), two reporting  
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28-day mortality (Gaulton et al., 2014; Wacharasint et al., 2013), one reporting 28-day, 60-day  
and 1-year mortality (Gaulton et al., 2015), and one reporting in-hospital, 90-day, and 1-year  
mortality (Prescott et al., 2014). All studies reported the association of obesity and sepsis  
mortality, while some also reported prevalence of source of sepsis infection (Arabi et al., 2013;  
Gaulton et al., 2015; Papadimitriou-Olivgeris et al., 2016) and associations between sepsis  
mortality and gender and comorbidities (Abbate et al., 2016; Gaulton et al., 2014; Gaulton et al.,  
2015; Nguyen et al., 2016; Prescott et al., 2014; Wacharasint et al., 2013). 
In looking at the relationship between obesity and sepsis mortality, three of the studies  
provide evidence to support the obesity paradox, or the association of reduced mortality from  
sepsis in obese or very obese patients compared to nonobese patients (Abbate et al., 2016;  
Nguyen et al., 2016; Wacharasint et al., 2013). Abbate and colleagues (2016) analyzed data from  
the California State Inpatient Database (SID), a subset of the Association of Health Research and  
Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP) database, and found that in  
2011 nonobese adults with sepsis had higher in-hospital mortality (27.4%) than obese adults  
(18.4%; absolute difference -9.0, 95% confidence interval [CI] -9.7−-8.3). These results are  
generalizable due to the large sample size, yet they are limited by the potential lack of full  
identification of obesity due to the use of administrative data. For instance, researchers identified  
obesity using the HCUP chronic-condition indicator as a Y/N variable rather than by using actual  
height and weight to calculate BMI.  Nguyen and associates (2016) examined the 2011  
Nationwide Inpatient Sample (NIS), which was also drawn from the HCUP SID and comprises 
data from more than 1,000 hospitals in the United States. The researchers concluded that, after  
adjustment, all-cause in-hospital mortality was lower (adjusted odds ratio [OR] = 0.84; 95% CI  
0.81−0.88) for obese sepsis patients as compared to nonobese ones. Similar to Abbate et al.  
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(2013), Nguyen et al. (2016) used administrative data rather than clinical data to determine  
obesity. Wacharasint et al. (2013) conducted post-hoc analysis of the Vasopressin and Septic  
Shock Trial (VASST) and found that obese patients had the lowest 28-day mortality followed by  
overweight patients, while patients with BMI < 25 kg/m2 had the highest mortality (p = 0.02).  
For every 1-unit increase in BMI, hazard ratio (HR)-adjusted mortality was 2% lower (95% CI  
0.97−0.99, p = 0.04). Variation in the remaining studies regarding examination of septic shock  
versus sepsis or severe sepsis limits ease of comparison among them. However, results regarding  
the association of obesity with reduced sepsis mortality across studies is promising. 
In contrast to studies that examined mortality in the short term, Prescott et al. (2014)  
examined the association of obesity and 1-year mortality after sepsis. They used data from the  
University of Michigan Health and Retirement Study (HRS), a longitudinal nationwide study  
supported by the National Institute on Aging and the Social Security Administration.  
Multivariate logistic regression models showed that higher BMI was associated with lower 1 
year mortality post sepsis. Compared with nonobese patients, obese (odds ratio = 0.59; 95% CI  
0.39–0.88) and severely obese patients (OR = 0.46; 95% CI 0.26–0.80) had the lowest mortality  
(Prescott et al., 2014). The authors found the same effect of BMI when they categorized patients  
by age < 70 and > 70 years. 
Of the remaining studies, five reported inconclusive results or conflicting evidence that  
there was no association between obesity and reduced short-term mortality from sepsis (Arabi,  
2013; Gaulton et al., 2014; Gaulton et al., 2015; Kuperman, Showalter, Lehman, Leib, & 
Kraschnewski, 2013; Papadimitriou-Olivgeris et al., 2016). Of these, two studies with strong  
methodologic soundness initially found obesity to be protective, yet, after adjustment for  
confounders, the association became insignificant (Arabi, 2013; Kuperman et al., 2013). Arabi et  
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al. (2013) interrogated a clinical database with information from medical centers in Canada, the  
United States, and Saudi Arabia (Cooperative Antimicrobial Therapy of Septic Shock [CATTS]  
group) and reported that patients who were obese (unadjusted OR 0.80, 95% CI 0.66−0.97) and  
very obese (unadjusted OR 0.61, 95% CI 0.44−0.85) had lower in-hospital mortality compared to  
normal-weight patients. These associations were insignificant, however, after adjustment for  
confounders. Kuperman et al. (2013) reported a clinically significant association between lower  
BMI and higher mortality, but the association failed to reach statistical significance (p = 0.06).  
However, when the researchers used BMI as a continuous variable, survivors had a higher BMI  
(27.6 kg/m2) than non survivors (26.3 kg/m2; p = 0.03). Kuperman et al. further reported that  
incidence of Type 2 diabetes and chronic obstructive pulmonary disease (COPD) were associated  
with BMI category (p < 0.01; p = 0.04, respectively). They also found that Type 2 diabetes was  
protective against sepsis-related mortality (OR = 0.53, 95% CI 0.32–0.88, p = 0.01), an  
association that remained when they excluded underweight patients due to low incidence of  
diabetes in that category (OR 0.54, 95% CI 0.32–0.91, p = 0.02). Independent risk factors for  
increased mortality were increasing age (in 5-year increments) and greater disease severity, as  
indicated by higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score  
(adjusted ORs = 1.12 and 1.14, respectively, p < 0.01). Neither sex nor race were associated with  
BMI or mortality (p < 0.01 and p = 0.03, respectively). 
The three studies that reported conflicting findings about the association between BMI  
and sepsis mortality and methodologic inconsistencies: all were conducted at a single medical 
center (Gaulton et al., 2014, 2015; Kuperman, Showalter, Lehman, Leib, & Kraschnewski, 2013;  
Papadimitriou-Olivgeris et al., 2016), one examined a population of presumed rather than  
confirmed sepsis (Gaulton et al., 2014), one was potentially underpowered in the BMI category  
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of morbid obesity (Gaulton et al., 2014), and one was conducted in a region with higher-than 
average rates of multidrug-resistant pathogens (Papadimitriou-Olivgeris et al., 2016). Gaulton et  
al. (2014) examined the Pennsylvania Integrated Clinical and Administrative Research Database  
(PICARD) and found that obesity was associated with higher sepsis-related mortality rates  
(24.4%) than non-obesity (21.2%; unadjusted OR 1.21, 95% CI 0.95–1.54, p = 0.12) and there  
was no linear association between BMI and mortality. In another study, Gaulton and colleagues  
(2015) found that 28-day sepsis-related mortality for normal weight was 22% versus for morbid  
obesity at 6.5% (p = 0.002). Indeed, these researchers found that obese and morbidly obese  
patients were less likely to die from sepsis-related causes within 28 days (OR 0.67, 95% CI  
0.46–0.95, p = 0.04), though there was no difference in mortality rates between groups for 60  
days and 1 year in adjusted and unadjusted models (Gaulton et al., 2015). 
Papadimitriou-Olivgeris et al. (2016) examined the effects of obesity in critically ill  
patients in a Greek ICU, including a subset of patients with sepsis. Researchers grouped patients  
by diagnosis into the categories of trauma, spontaneous intracranial hemorrhage, sepsis,  
postoperative observation, respiratory insufficiency, and other, which included coma, epilepsy,  
and intoxication. Total ICU mortality (N = 834) was 22.5%, with a mortality rate for nonobese  
patients of 21% and for obese patients 28.8% (p = 0.036). For patients with sepsis (n = 125),  
more nonobese patients survived (76.3%) than obese patients (43.7%; p = 0.001), and  
multivariate analysis indicated increased risk of mortality for higher Sequential Organ Failure  
Assessment (SOFA) score upon admission (OR 1.3, 95% CI 1.1−1.5, p = 0.003), obesity (OR 
5.3, 95% CI 1.4−20.2, p = 0.014), pneumonia (OR 3.5, 95% CI 1.1−11.3, p = 0.015), and  
development of septic shock (OR 3.4, 95% CI 1.3−9.1, p = 0.015) and decreased risk of  
mortality for urinary tract infection (OR 0.06, 95% CI 0.01−0.52, p = 0.038). These results  
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should be interpreted with caution given the small size of the sample of sepsis patients and the  
comparison with five other diagnoses with very different disease trajectories. Further, the  
associations of septic shock, pneumonia, and high SOFA with increased mortality among  
patients with sepsis are unsurprising given that these conditions are associated with increased  
disease severity. 
Discussion 
The current literature on the relationship between mortality in sepsis and obesity consists  
of retrospective cohort studies that primarily describe this association in hospital or at 30 days.  
Few studies that we found explored follow-up periods of 60 or 90 days, and only one study had a  
1-year follow-up. These time frames leave significant gaps in data because, of patients that  
survive sepsis to 30 days, as many as one-third die before 6 months (Prescott, Osterholzer,  
Langa, Angus, & Iwashyna, 2016; Shankar-Hari & Rubenfeld, 2016; Yende, Austin, & Rhodes,  
2016), and the risk of death extends up to 10 years after hospitalization (Linder et al., 2014).  
Prospective cohort studies or controlled longitudinal studies would provide a value-added  
contribution to this topic. In one such study, Prescott and colleagues (2016) examined  
longitudinal cohort data, comparing patients with sepsis against adults not currently hospitalized,  
hospitalized patients with non-sepsis infection, and hospitalized patients with acute sterile  
inflammation. Their goal was to assess the risk factors and confounders associated with late (31  
days to 2 years) sepsis mortality. Sepsis patients experienced a 22.1% absolute increase (95% CI  
17.5−26.7%) in late mortality when compared to non-hospitalized adults, a 10.4% increase when 
compared to hospitalized patients with non-sepsis infection (95% CI 5.4−15.4%), and a 16.2%  
increase compared to hospitalized patients with a sterile inflammatory diagnosis (95% CI  
10.2−22.2%). These results support the need for similar research that incorporates the variable of  
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obesity to better understand the impact of obesity on long-term sepsis outcomes.  
Despite criticism for its inability to discriminate between lean and fat mass (Nuttall,  
2018), BMI is currently the most commonly used method to estimate obesity in adults (Shah &  
Braverman, 2012). WHO and NIH classify body mass categories using the same BMI ranges,  
which assists in interpretation of results across studies. ICD-9 codes, which are used to identify  
diagnoses for insurance reimbursement purposes, are a less reliable method for identifying  
obesity because they may not be accurately coded in administrative data (Mocarski, Tian,  
Smolarz, McAna, & Crawford, 2018). Chronic conditions are coded only when they apply to the  
patient’s present treatment, not if those conditions are no longer actively being treated (Hill,  
1999). Using derived clinical data from the electronic health record (EHR) is a more accurate  
method for determining body mass category (Mocarski, Tian, Smolarz, McAna, & Crawford,  
2018). While indirect measures of body fat are more reliable, such as dual energy x-ray  
absorptiometry (DEXA) scans, computed tomography (CT) scans, bioelectric impendence  
analysis, underwater weighing, and air displacement and density measures (Bod Pod), they are  
expensive and impractical (Nuttall, 2018).  
Investigators in the reviewed studies identified sepsis using a variety of methods,  
including the 1992 and 2001 consensus definitions (Bone et al., 1992; Levy et al., 2002),  
administrative identification via ICD-9 codes, physician diagnosis, and an antibiotic algorithm  
for presumed sepsis. The most problematic of these methods is inclusion of presumed sepsis to  
estimate mortality, as patients may have been inappropriately assigned to the antibiotic 
algorithm. Use of clinical data such as blood-culture results would strengthen this approach so  
that cases of confirmed sepsis could be compared against cases of unconfirmed sepsis. The  
ACCP/SCCM first published consensus definitions for systemic inflammatory response  
19 
 
syndrome (SIRS), sepsis, severe sepsis, septic shock, and multiple organ dysfunction along with  
scoring methods for determining severity and assess mortality in 1992 (Bone et al., 1992). In  
recognition of the limitations of applying these complex descriptions in practice, the  
ACCP/SCCM published revisions in 2001 that refined the definitions, expanded the list of  
diagnostic criteria, and proposed a classification scheme for sepsis to stratify patients called  
PIRO: Predisposing conditions, nature and extent of the Insult, nature and magnitude of the host  
Response, and degree of Organ dysfunction present (Levy et al., 2003). Accurate identification  
of sepsis remains challenging, as evidenced by the evolution of consensus statements, the latest  
of which (Sepsis-3) incorporate a refined understanding of the pathophysiology of sepsis,  
moving away from emphasizing SIRS as the underlying mechanism and recognizing the role of a  
maladaptive host response as the major issue that results in the tissue damage and altered organ  
function in sepsis (Singer et al., 2016). Using this new definition and incorporating severity  
scores such as SOFA to estimate the extent of organ dysfunction is a more precise way to  
identify the severity of sepsis. 
While evidence supporting the association between obesity and lower sepsis mortality is  
promising, descriptions of causal mechanisms are still lacking. One commonly proposed  
mechanism that links obesity and sepsis is inflammation. Sepsis is an example of acute  
inflammation that is brief in duration and begins with the production and release of chemical  
mediators to destroy and remove pathogens as the initial normal response of the body to protect  
against infection or injury. Obesity, meanwhile, represents chronic inflammation that occurs as a 
result of a maladaptive process where persistent low-grade inflammation causes tissue  
destruction over time (Makki, Froguel, & Wolowczuk, 2013).  
Adipose tissue, present in excess in obesity, is an active immune organ that produces  
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cytokines and chemokines, vasoactive and coagulation factors, regulators of lipoprotein  
metabolism and proteins that participate in the inflammatory response (Lehr et al., 2012;  
Mohamed-Ali, Pinkney, & Coppack 1998; Romacho, Elsen, Rohrborn, & Eckel, 2014). Chronic  
inflammation occurs as adipose cells hypertrophy, stimulating enhanced adipokine production  
and increased infiltration of pro-inflammatory immune cells (Sell, Habich, & Eckel, 2012)  
resulting in endothelial-cell dysfunction, oxidative stress, and the activation of circulating  
immune cells (Singer & Granger, 2007). Adipose-cell hypertrophy is associated with increased  
expression of the pro-inflammatory markers interleukin-6 and leptin, while the anti 
inflammatory marker adiponectin is decreased (Singer & Granger, 2007). Taken together, these  
actions contribute to a maladaptive inflammatory response.  
The metabolic alterations seen in acute and chronic inflammation are similar, including  
insulin resistance and elevation of leptin, IL-6, and C-reactive protein (CRP; Wisse, 2004).  
Typically, leptin and adiponectin work in balanced opposition (Guzik, Mangalat, & Korbut,  
2006; Trayhum & Wood 2004), but unique to chronic inflammation from obesity, leptin and IL-6  
are upregulated, while adiponectin is downregulated (Fantuzzi, 2009; Fantuzzi, 2013).  
Subsequently, leptin and IL-6 spill over into peripheral tissues causing insulin-receptor resistance  
(Ye & McGuinness, 2013). Importantly, a similar effect occurs with leptin: leptin secretion  
increases as adipose tissue expands, and when this is coupled with leptin-receptor resistance  
there is increasing leptin mRNA expression, contributing to hyperleptinemia (Tschöp et al.,  
2010; Ye & McGuinness, 2013).  
Summary and Conclusions 
     This review revealed conflicting results. Of the nine studies included, three support the 
association of lower mortality with obesity in sepsis (Abbate et al., 2016; Nguyen et al., 2016; 
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Wacharasint et al., 2013), and one found that obesity was associated with lower 1-year mortality 
in sepsis compared non obesity (Prescott et al., 2014). Each of the three studies whose findings 
refuted the obesity paradox were conducted at a single center (Gaulton et al., 2014; Gaulton et 
al., 2015; Papadimitriou-Olivgeris et al., 2016). Future research should be directed toward 
studying prospective cohorts and examining the effects of the association of obesity and sepsis 
on longer-term mortality and on related persistent residual symptoms of post sepsis frailty.   
     To summarize the inflammatory processes in obesity, the immune function of adipose  
tissue is upregulated. Cytokine and chemokine regulation is altered, resulting in increased  
expression of the pro-inflammatory markers IL-6 and leptin, while the anti-inflammatory marker  
adiponectin is decreased (Singer & Granger, 2007). When the excessive inflammation of sepsis  
is modulated due to the chronic inflammation of obesity, the result is a more balanced  
physiologic response that causes less endothelial damage, less capillary permeability and  
ultimately less organ dysfunction. Research that examines the associations among inflammatory  
biomarkers, sepsis, and obesity may help to uncover the nature of these relationships, furthering  
our understanding of these mechanisms and leading to innovative interventions and treatment  
strategies.  
     The obesity paradox is not unique to sepsis but has been seen in other inflammatory  
diseases including heart disease (De Schutter et al., 2016), pneumonia (Braun et al., 2017), and  
acute kidney injury (Hafner, Hillenbrand, Knippschild, & Radermacher, 2013). Research that  
seeks to describe the phenotype of sepsis survivors by stratifying risk factors and controlling for  
confounders will be instrumental in developing targeted interventions to improve sepsis  
outcomes.  
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Table 1 
 
Studies examining obesity and sepsis mortality in adults.  
 
First Author, 
year, STROBE 
Score 
 
Objective  Research 
design 
Sample  Statistical 
analysis 
Main outcomes 
Abbate, 2016 
STROBE Score: 21 
 
To determine if 
age modifies the 
association 
between obesity 
and mortality in 
sepsis 
 
 
Retrospective
, cohort  
2010 - 2011 
N= 116,566 
sepsis 
n = 13,991 
(12%) coded 
as obese 
n = 30, 712 
(26.3%) 
coded as 
death in 
hospital 
 
California 
State 
Inpatient 
Database 
 
Defined 
obesity has a 
binary Y/N 
variable 
using ICD-9 
based 
chronic 
disease 
indicators 
 
Defined 
sepsis with 
ICD-9 codes 
for severe 
sepsis and 
septic shock  
 
 
Multivaria
te logistic 
regression  
Obesity 18.4% 
Non Obesity 
27.4% (After 
adjusting for 
covariates 
absolute 
difference -9.0%, 
95% CI, -9.7 to -
8.3) 
 
 
Obesity and older 
age associated 
with decreased 
mortality (P < 
0.001) 
Age < 50 years 
and obesity (OR 
0.99, 95% CI, 
0.87- 1.13) 
Age > 50 years 
and obesity (OR 
0.65, 95% CI, 
0.62-0.68) 
 
Arabi, 2013 
STROBE 
Score: 20 
 
To examine the 
impact of obesity on 
hospital mortality in 
septic shock 
Secondary aim to 
examine ICU 
mortality and 
hospital length of 
stay 
 
 
Retrospective, 
cohort 1996 - 
2006 
N= 8,670 
n = 2, 882 with 
documented 
height and 
weight 
Cooperative 
Antimicrobial 
Therapy of 
Septic Shock 
(CATSS) (28 
medical centers 
in Canada, 
Analysis of 
variance (ANOVA) 
Chi-square  
Multivariate 
logistic regression 
Unadju
sted 
hospita
l 
mortali
ty by 
weight 
group: 
Under
weight 
61.7%, 
Normal 
30 
 
United States, 
Saudi Arabia) 
 
Defined sepsis 
using 1992 
AACP 
Guidelines 
 
Defined obesity 
using WHO 
criteria 
weight 
56.9%, 
Overw
eight 
54.4%, 
Obese 
51.3%, 
Very 
Obese 
44.7% 
(P = 
0.003). 
Becam
e 
insignif
icant 
when 
adjuste
d for 
confou
nders. 
 
Obese 
and 
Very 
Obese 
categor
ies 
were 
associa
ted 
with 
more 
gram 
positiv
e 
infectio
ns, 
more 
skin/s
oft 
tissue 
infectio
ns, and 
less 
pneum
onia 
 
Obese 
categor
ies had 
more 
diabete
s and 
related 
31 
 
compli
cations 
 
Gaulton, 2014 
STROBE 
Score: 21 
 
To define 
a novel association 
between obesity 
and mortality in 
sepsis, and to 
identify a potential 
high-risk 
population for 
future targeted 
interventions 
 
 
Retrospective, 
cohort  
March 1, 2007 – 
June 30, 2011 
N = 1835  
n = 1779 after 
exclusion for leg 
amputation, 
pregnancy, or 
missing height 
and weight 
 
7.1% 
Underweight 
60.6% Non-obese 
32.2% Obese 
 
Pennsylvania 
Integrated Clinical 
and 
Administrative 
Research 
Database 
(PICARD) 
 
Used UPHS 
antibiotic 
algorithm for 
presumed sepsis  
treatment  
 
Defined obesity 
using WHO 
criteria  
 
Wilcoxon 
Rank Sum  
Chi-square 
Forward 
selection 
logistic 
regression 
28 day 
mortality 
overall 
22.1% 
Non 
obese 
21.1% 
Obese  
24.4% 
(Unadjust
ed OR 
1.21, 95% 
CI, 0.95-
1.54, P = 
0.12) 
 
No effect 
noted by 
gender (P 
= 0.59), 
admissio
n to 
hospital 
(P = 
0.54), or 
ICU 
location 
(P = 0.29) 
 
No linear 
associatio
n 
between 
BMI and 
mortality 
(P = 0.14) 
 
Severely 
obese 
higher 
odds of 
mortality 
after 
adjustme
nt for 
sepsis 
severity 
compared 
to normal 
group 
(OR 1.53, 
95% CI, 
32 
 
0.96 0 
2.36, P = 
0.05) 
 
Gaulton, 
2015 
STROBE 
Score: 21 
 
to determine if 
BMI is 
associated with 
28-day 
mortality in a 
patient 
population 
presenting to 
the emergency 
department 
with severe 
sepsis or septic 
shock 
 
 
Retrospective, 
cohort  
January 2005 – 
October 2007 
N = 1324 
n = 1191 after 
excluding for 
missing or 
unreliable data 
 
54.7% male 
53.6% African 
American 
57 median age 
(IQR 45-69) 
25.1 median BMI 
 
Pennsylvania 
Integrated Clinical 
and 
Administrative 
Research Database 
(PICARD) 
 
Sepsis defined 
using 2001 
consensus 
recommendations 
 
Obesity defined 
using NIH criteria 
Wilcoxon Rank 
Sum  
Kruskal–Wallis  
Chi square 
Multivariate 
logistic 
regression  
5 Knot 
restricted cubic 
spline 
regression 
Overall 
cohort 
mortality 
19.9% at 28 
days; 24.4% 
at 60 days 
 
Mortality at 
28 days for 
normal 
weight 22% 
vs morbid 
obesity 
6.5% (P = 
0.002) 
 
Obese and 
morbid 
obese were 
less likely to 
die (OR 
0.67, 95% 
CI, 0.46 – 
0.95, P = 
0.04) 
 
No 
difference in 
mortality 
between 
groups for 
60 days and 
1 year in 
adjusted 
and 
unadjusted 
models 
 
Obese and 
morbidly 
obese more 
likely to 
have soft 
tissue 
infections 
 
Morbidly 
obese were 
younger 
 
33 
 
Overweight, 
obese, 
morbidly 
obese had 
more 
comorbidity 
of diabetes, 
hypertensio
n, chronic 
heart 
failure, and 
less 
comorbidity 
of cancer 
and 
immunosup
pression 
 
      
Kuperma
n, 2013 
STROBE 
score: 21 
 
To 
determine 
the 
associatio
n between 
BMI and 
survival in 
patients 
admitted 
with a 
diagnosis 
of sepsis 
 
 
Retrospective, 
cohort  
July 1, 2007 - June 
30, 2010 
N = 792 
 
24% obese 
6% morbidly 
obese 
 
Penn State Milton 
S. Hershey Medical 
Center 
 
Defined obesity 
using WHO criteria  
 
Defined sepsis 
with ICD-9 codes 
for sepsis, severe 
sepsis, septic 
shock  
 
 
 
Analysis of variance 
(ANOVA) Chi-square 
Cochran-Armitage 
Multivariate logistic 
regression 
Odds ratio for 
mortality was 
1.5 (95% CI 
0.67-6.3) for 
underweight 
patients and 
0.7 (95% CI 
0.12 – 4.2) for 
those with 
morbid 
obesity (P = 
0.19) 
 
BMI as a 
continuous 
variable, in-
hospital sepsis 
survivors had 
a BMI of 27.6 
kg/m2,compar
ed with 26.3 
kg/m2 among 
non- survivors 
(P = 0.03) 
 
Diabetes was 
protective 
against death, 
with an odds 
ratio for 
mortality of 
0.53 (95% CI 
0.32-0.88, P = 
0.01) 
 
34 
 
Nguyen, 2016 
STROBE Score: 
21 
 
To 
exami
ne the 
associ
ation 
betwe
en 
obesit
y and 
all-
cause 
morta
lity, 
length 
of stay 
and 
hospit
al cost 
amon
g 
patien
ts 
with 
sepsis 
20 
years 
of age 
or 
older 
 
 
Retrospective, 
cohort 
 2011 
N = 1,763,000 
 
50.6% female 
34.7% severe 
sepsis 
20.9% septic 
shock 
 
Nationwide 
Inpatient 
Sample (NIS) 
of Healthcare 
Cost and 
Utilization 
Project 
(HCUP) 
 
Defined 
obesity  as  
30 using 
Elixhauser 
comorbidity 
measure 
 
Defined 
sepsis with 
ICD-9 codes 
for sepsis, 
severe sepsis, 
septic shock 
Wilcoxon Rank 
Sum  
Chi-square 
tests  Pearson’s 
correlation 
Multivariate 
logistic 
regression  
Overall sepsis 
mortality rate was 
14.8% 
Sepsis 14.3% 
Severe sepsis 
28.2% 
Septic shock 35.4% 
 
After adjustment 
obesity was 
association with 
16% decrease in 
odds of dying (OR 
0.84, 95% CI, 0.81-
0.88).  
 
Obesity more likely 
to be female, 
younger, lower 
income area, less 
likely to have 
Medicare 
 
Obesity more likely 
to have chronic 
heart failure, 
pulmonary 
circulatory 
disorders, diabetes, 
hypertension, liver 
disease, renal 
failure, depression, 
psychoses, 
deficiency anemia, 
arthritis, 
hypothyroid 
 
Non obesity more 
likely to have AIDS, 
alcohol abuse, drug 
abuse, fluid and 
electrolyte 
disorders, 
coagulopathy, 
cancer, valvular 
heart disease, 
paralysis, 
neurological 
disorders 
 
Pre
scot
t, 
201
4 
To determine 
whether 1-year 
mortality, 
healthcare 
utilization, and 
Retrospective, cohort 
1998 – 2004 baseline  
data and claims based 
data for 1998 - 2005 
N = 1524 
n = 1404 
after 
exclusion 
for missing 
Kruskal-Wallis  
Chi-square test 
Multivariate 
logistic 
regression 
Increasing BMI was 
associated with lower 
in hospital, 90 day and 
1 year mortality. 
Normal weight 62% 
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STR
OB
E 
Sco
re: 
22 
 
functional 
outcomes 
following a 
severe sepsis 
hospitalization 
differ by body 
mass index 
 
 
height and 
weight or 
underweig
ht 
 
42.5% 
normal 
weight 
33.7% 
overweight 
23.8% 
obese or 
severely 
obese 
 
Health and 
Retirement 
Study 
(HRS) 
 
Definition 
of sepsis 
based on 
ICD-9 
claims 
 
Defined 
obesity 
using WHO 
criteria 
Kaplan Meier 
Curve 
Overweight 53.1% 
Obese 46% 
Severely Obese 44.7% 
(P < 0.001) 
 
Obese (OR 0.59, 95% 
CI, 0.39-0.88) 
Severely Obese (OR 
0.46, 95% CI, 0.26 – 
0.80) (P < 0.001) 
 
Obese patients were 
more like younger (P < 
0.001), female (P < 
0.001), less wealthy (P 
< 0.001), had diabetes 
(P< 0.001), had more 
renal dysfunction (P = 
0.001), had more ADL 
baseline limits (P = 
0.02) 
 
Kaplan Meier curve 
BMI was associated 
with lower morality (P 
< 0.001) 
 
Wacharasin
t, 2013 
STROBE 
Score: 21 
 
To determine 
whether being 
overweight or 
obese altered (a) 
mortality and 
organ dysfunction 
outcomes of sepsis, 
(b) pattern of 
susceptibility to 
infection, (c) 
treatment received 
by patients, or (d) 
the inflammatory 
response to sepsis 
 
 
Retrospectiv
e, cohort  
2001-2006 
N = 778 
 
n = 730 with 
height and 
weight 
measured of 
which  
n = 250 BMI < 
25 
n = 209 BMI 25- 
29.9 
n = 245 BMI  
30 
 
n = 396 
vasopressin 
group  
of which  
n = 47 BMI < 25 
n = 13 BMI 25-
29.9 
n = 16 BMI  30 
 
n = 382 
inflammatory 
Kruskal- 
Wallis 
Chi 
Square 
Log rank 
(Mantel 
Cox) 
hazard 
ratio 
Kaplan 
Meier 
curve 
Mortality at 28 days 
was lower in (BMI 25- 
29.9 and  BMI  30 vs 
BMI < 25 (P = 0.02).  
BMI < 25 vs BMI 25- 
29.9 (P = 0.10). BMI < 
25 vs BMI  30 (P = 
0.01). BMI 25-29.9 vs 
BMI  30 (p = 0.2). 
 
For every 1 unit 
increase in BMI, HR 
adjusted mortality was 
2% lower (95% CI, 
0.97-0.99, P = 0.04) 
 
Median BMI: 
BMI < 25 = 23; BMI 
25- 29.9 = 28; BMI  
30 = 34 
 
Obese patients less 
likely to be male (BMI 
< 25 = 62%;   
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cytokine group 
of which  
n = 138 BMI < 
25 
n = 112 BMI 25-
29.9 
n = 132 BMI  
30 
 
Vasopressin and 
Septic Shock 
Trial (VASST) a 
multicenter 
randomized 
doubled blind 
controlled trial 
 
Defined obesity 
using NIH 
criteria and 
collapsed 
underweight 
and normal 
weight into BMI 
< 25 
 
Defined sepsis 
using 1992 
AACP Guidelines 
 
 
 
BMI 25- 29.9 = 67.9%;  
BMI  30 = 55.5% (P = 
0.03) 
 
Obese patients more 
likely to have diabetes 
(BMI < 25 = 14.9%;   
BMI 25- 29.9 = 20.6%;  
BMI  30 = 29.8% (P < 
0.0001) 
 
Lower rates of lung 
infection found in 
overweight and obese 
(BMI < 25 = 49.8%;   
BMI 25- 29.9 = 45%;  
BMI  30 = 35% (P = 
0.003) 
 
IL-6 was blunted in 
overweight and 
obesity in early septic 
shock (BMI < 25 = 235 
(IQR 44- 1793 pg/ml);   
BMI 25- 29.9 = 190 
(IQR 44-2339 pg/ml); 
BMI  30 = 106 (IQR 
34 – 686 pg/ml) (P = 
0.046) 
 
No differences in 
APACHE II, lactate, 
WBC, platelets, MCP-1, 
TNF-, resistin 
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Abstract 
 
 Sepsis is a life threatening syndrome that occurs in response to a severe infection.  In 
recent years the understanding of the pathobiology of sepsis has been refined, with research 
describing the altered host response as the underlying cause.  Survivors of sepsis often have long 
hospital stays and suffer from subsequent frailty and long-term health consequences.  Predicting 
attributes of sepsis survivors remains challenging, however an “Obesity Paradox” exists wherein 
obese individuals survive sepsis at higher rates than their normal weight counterparts. We 
present a model that describes the relationships between sepsis and obesity, focusing on 
inflammation as a shared pathway for dysregulation in obese versus healthy weight adults.  
Understanding the interaction of these complex variables is an important first step toward 
developing interventions and treatments to augment sepsis survival. 
 Keywords: sepsis, obesity, mortality, survival 
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Introduction 
Sepsis is a life-threatening syndrome in which complex biologic systems respond to 
pathogenic invaders with pro- and anti- inflammatory responses in a manner that evolves over 
time, typically resulting in a dysregulated, or exaggerated, host response (Singer et al., 2016).  
Not only is sepsis a public health priority in the United States (US), affecting 1.7 million adults 
per year (CDC, 2016), it is a global health burden with an estimated 30 million cases and 6 
million deaths per year (Reinhart, Daniels, Kissoon, Machado, Schachter, & Finger, 2017).  In 
response to this crisis The World Health Assembly (WHA) has published recommendations for 
researchers and clinicians centered on prevention, early diagnosis, and management of sepsis to 
reduce premature deaths and reduce effects of long-term disability for survivors (Reinhart et al., 
2017).  The National Institute of Nursing Research (NINR) supports nursing science aimed at 
developing new biological knowledge that will translate into improving patient health outcomes 
and reducing disabling effects of symptoms (NINR, 2016).  Identifying sepsis phenotypes is 
critical to the goal of promoting early diagnosis and management support.  In recent years an 
“obesity paradox” has been observed in sepsis where obese patients survive at higher rates than 
their non-obese counterparts (Abbate, 2016; Arabi, 2013; Meyer et al., 2018; Nguyen et al., 
2016; Wacharasint, Boyd, Russell, & Walley, 2013).  Identifying the causal mechanisms and 
teasing out characteristics of an obese-sepsis phenotype is one step toward meeting the goals of 
the WHA and the NINR.  The causal mechanisms for the obesity paradox have not been fully 
described, nor is there an established theoretical framework in which to test the salient variables 
thought to contribute to this phenomenon.  We present a model that describes the relationships 
between sepsis and obesity, focusing on inflammation as a shared pathway for dysregulation in 
obese versus healthy weight adults, that affects mortality rates.  Research to explain this 
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phenomenon may lead to interventions that aid in early diagnosis by identifying patient 
phenotypes and may contribute to management algorithms that can reduce the burden of 
debilitation and persistent symptoms for survivors.   
Concepts 
Inflammation 
As a protective mechanism the body responds to noxious stimuli, such as a pathogenic 
invader, with the inflammatory response to communicate exposure and to contain the foreign 
substance (Bennett, Reeves, Billman, & Sturmberg, 2018; Del Giudice & Gangestad, 2018).  
Governed by immune-regulatory pathways the sympathetic nervous system (SNS) triggers 
peripheral pro-inflammatory responses, while the parasympathetic nervous system (PNS) and the 
neuroendocrine hypothalamic-pituitary-adrenal (HPA) axis balance sympathetic effects by 
inhibiting inflammatory responses, and SNS, PNS and HPA pathways are mediated by cytokine 
and hormonal influences (Bennett et al., 2018).  At the intersection of the immune and 
neuroendocrine systems, cytokines and immune mediators released during the immune response 
can activate neural responses that exaggerate local inflammation, but that can also activate 
neuroendocrine responses to restore homeostasis (Bennett et al., 2018).  
The ubiquitous goal of non-specific inflammation is to increase blood flow, dispatch 
white blood cells to infiltrate the area and isolate the threat, and increase phagocytosis to remove 
the threat.  Normally, this process is followed by down-regulation of inflammation to promote 
healing and maintain homeostasis (Bennett et al., 2018).  When the body is invaded or injured 
the inflammatory response is activated causing monocyte-macrophage cells to be released, 
followed by the release of cytokines and chemokines, such as interleukin-6 (IL-6) and tumor 
necrosis factor-alpha (TNF-α), that mediate non-specific cellular, tissue, and vascular damage 
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(Bennett et al., 2018; Del Giudice & Gangestad, 2018). The activity of monocyte-macrophage 
cells is heightened in the state of obesity and is a likely confounding factor contributing to the 
obesity paradox.  
Obesity 
Characterized by excess adipose tissue, obesity is a global health concern that increases 
risk of comorbidities, decreases life expectancy, and results in 2.8 million deaths annually (Pal, 
Pal, Babu, & Lalitha, 2015).  Antecedents of obesity include caloric energy intake and usage 
imbalance, decreased physical activity, and genetic predispositions (Pal et al., 2015).  Recent 
observations point to socioeconomic status and environmental factors causing epigenetic 
modifications as well (Vecchié et al., 2018).  Obesity is associated with several disorders such as 
metabolic syndrome, type 2 diabetes, cardiovascular disease, lipid disorders, stroke, sleep apnea, 
and cancer (CDC, 2018).  In the US, middle aged (40.2%) and older adults (37%) as well as non-
Hispanic blacks (48.1%) and Hispanics (42.5%) have higher rates of obesity than other groups 
(CDC, August 13, 2018).  The economic burden of obesity was estimated at $147 billion in the 
US in 2008 (CDC, August 13, 2018). 
Obesity definition. 
The World Health Organization defines obesity as an accumulation of abnormal or 
excessive fat that is a risk to health (WHO, 2019). The Obesity Society elaborates, defining 
obesity as a chronic disease with multiple phenotypes resulting from long term positive energy 
balance and excess adiposity that leads to physiologic abnormalities (Kelly, Kahan, Heymsfield, 
Kotz, & Jastreboff, 2019).  Obesity is a clinical diagnosis that is determined by Body Mass Index 
(BMI), a surrogate measure of body fat, (CDC, n.d.).  BMI is an index of weight adjusted for 
height calculated as weight in kilograms divided by the square of the height in meters (kg/m2). 
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Based on range of BMI individuals are classified as underweight (BMI < 18.50 kg/m2), normal 
weight (BMI = 18.50 to 24.99 kg/m2), overweight (BMI = 25.0 to 29.99 kg/m2), obese (BMI = 
30.0 to 39.99 kg/m2) or very obese (BMI > 40 kg/m2) (WHO, November 2016).  A limitation of 
BMI is that individuals with varying clinical and biochemical characteristics are in the same 
category, regardless of emerging evidence of obesity phenotypes (Vecchié et al., 2018).  Despite 
this limitation, BMI is still accepted internationally by researchers as the standard method for 
identifying and defining obesity (Engin, 2017). 
Neurophysiologic control of energy balance and regulation of body weight occurs along 
the HPA axis.  In obesity, chronic low grade inflammation increases pro-inflammatory cytokines 
while alteration in the HPA axis increases catecholamine and glucocorticoid levels that together 
contribute to modulation of immune function (Pal et al., 2015), (Figure 1).  The consequences of 
obesity stem from the activity of adipose tissue, which is up regulated when it is present in 
excess.  Adipose tissue secretes a large number of adipokines that have integral roles in 
immunometabolism.  For example, chronic low grade inflammation occurs when macrophages 
preferentially take up residence in adipose tissue (Na, Je, & Seok, 2018) leading to cytokine IL-
6, CRP, and TNF-α up regulation, while parallel up regulation of the pro-inflammatory 
adipokine leptin and down regulation of the anti-inflammatory adipokine adiponectin takes place 
(Cottam et al., 2004).  Despite the subsequent hyperleptinemia, leptin is biologically unavailable, 
thus the effects of leptin are often not observed in obesity and leptin resistance is independently 
associated with insulin resistance, suggesting that leptin receptor activity may be altered 
(Sudhakar, Silambanan, Chandran, Prabhakaran, & Ramakrishnan, 2018).  CRP, a protein that 
increases significantly in concentration during inflammation and obesity, has been found to be 
independently associated with changes in leptin levels and researchers have hypothesized that 
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CRP interacts with the leptin receptor, linking CRP and leptin to immune function.  Receptor 
resistance associated with obesity is not a novel concept.  Insulin resistance has been widely 
accepted as a consequence of obesity for many years (Dandona, Aljada, & Bandyopadhyay, 
2004; Jung, Jung, Reaven, & Kim, 2018) 
Figure 1 
A hypothesized model of inflammatory modulation. The hypothalamus-pituitary-adrenal axis 
exerts action on cellular mechanisms in both obesity and inflammation, adapted from Pal et al., 
(2015). In obesity there is heightened immunometabolic activity, inducing a state of chronic low 
grade inflammation. Macrophages/monocytes that take up residence in adipose tissue alter 
immunometabolic inflammation where the cytokines IL-6, CRP, TNF-α, and leptin are up 
regulated while parallel down regulation of the anti-inflammatory adipokine adiponectin occurs 
(Cottam et al., 2004).  It has been established that there is a relationship between adipokines 
(adiponectin and leptin) and decreased insulin sensitivity and insulin resistance. Depicted in blue, 
this model hypothesizes that a similar mechanism occurs wherein there is increased, but 
biologically unavailable leptin, due to leptin receptor resistance, which contributes to 
inflammatory modulation. 
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Sepsis 
Sepsis is a heterogeneous syndrome where the host response to inflammation and 
infection becomes excessive, causing harm to the epithelium and capillary leakage, leading to 
organ failure and death (Cohen et al., 2015).  Sepsis with organ dysfunction (severe sepsis) and 
septic shock is associated with higher mortality rates, up to 50%, while general sepsis has a 
mortality rate of less than 20% (De La Rica, Gilsanz, & Maseda, 2016).  Mansur et al. (2015) 
reported a 71% increase in cases of severe sepsis between 2003 and 2007 and reported that total 
costs for all patients with severe sepsis increased 57% in the same time period.  The approximate 
cost of sepsis care in 2008 was $14.6 billion (Hall, Williams, DeFrances, & Golosinskiy, 2011).  
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The risk factors for sepsis are varied.  More than half of the cases of severe sepsis occur 
in adults over age 65 (Mayr, Yende, & Angus, 2014).  Although sepsis can occur in both sexes it 
is more common in males (De La Rica et al., 2016; Sakr et al., 2012).  Black race has been 
reported to have a higher incidence of both sepsis and severe sepsis than their white counterparts 
(Barnato, Alexander, Linde-Zwirble, & Angus, 2008; Dombrovskiy, Martin, Sunderram, & Paz, 
2007); in fact, De La Rica and colleagues (2016) found that in the United States blacks had a 2-
fold greater probability of experiencing sepsis.  Over half of the patients with sepsis have chronic 
comorbid conditions such as diabetes, congestive heart failure, chronic pulmonary disease, 
cancer, and chronic renal failure (De La Rica et al., 2016; Mayr et al., 2014).  
Sepsis definition. 
While systemic inflammatory response syndrome (SIRS) has been the focus of sepsis 
research for the last two decades (Bone et al., 1992; Levy et al., 2003), a refined understanding 
of the pathophysiology now points to an altered host response as the underlying cause of sepsis 
(Singer, Deutschman, Seymour, Shankar-Hari, et al., 2016).  When the body encounters a 
pathogenic invader, an inflammatory and immune response occurs in attempt to isolate the 
threat.  If not contained, the pathogenic invader can result in infection and the immune response 
will trigger the release of leukocytes to systemically counteract the pathogenic invader in an 
attempt to recover (Figure 2).  However, in sepsis the host inflammatory response is so excessive 
that the cytokine storm causes epithelial damage, increased capillary permeability, organ 
dysfunction, and even death (Winters et al., 2010), (Figure 2).  Of course, at any point in this 
process, recovery could either occur spontaneously, or more likely, due to aggressive medical 
treatment, but currently 1 in 3 hospital deaths are due to sepsis (CDC, 2016).  However, an 
“obesity paradox”, whereby obese patients with sepsis survive at higher rates than their non-
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obese counterparts has been documented (Abbate, 2016; Nguyen et al., 2016; Prescott, Langa, 
Liu, Escobar, & Iwashyna, 2014; Wacharasint et al., 2013).  In fact, increased BMI has been 
associated with decreased mortality from post-operative sepsis (Davenport et al., 2009; 
Memtsoudis et al., 2012), community acquired pneumonia (Braun et al., 2016), and septic shock 
(Arabi, 2013; Wacharasint et al., 2013).  
Figure 2 
A comparison of the normal response to infection and the dysregulation response in sepsis. 
The normal response to infection is depicted, where a pathogen elicits the ubiquitous acute 
inflammatory response, which is followed by the activation of cellular immunity, including 
release of the leukocytes called macrophages/monocytes, followed by recovery, or a state of 
infection that typically leads to recovery. In sepsis (depicted in red) the body responds to 
infection in a dysregulated, over-active manner by releasing cytokines excessively.  The physical 
effect to the cytokine storm is damage from epithelial injury, increased capillary permeability, 
and organ dysfunction. Together this damage is responsible for high mortality rates from sepsis. 
 
Normal response to infection: 
 
 
Dysregulated response to infection in sepsis: 
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Relationship between Obesity and Sepsis 
 Inflammation is the common pathway shared by obesity and sepsis.  Obesity is associated 
with chronic low grade inflammation whereas sepsis is an acute state of inflammation and 
dysregulated host response.  Taken together, the model presented in Figure 3 hypothesizes this 
that obesity related chronic inflammation, characterized by up regulation of the pro-
inflammatory markers IL-6, CRP, and leptin actually modulates the insult from sepsis. 
Therefore, when the excessive inflammation of sepsis occurs, the effect is less severe and the 
result is a more balanced physiologic response that causes less endothelial damage, less capillary 
permeability and ultimately less organ dysfunction (Figure 3).  
Figure 3 
The hypothesized relationship between obesity, sepsis, and sepsis mortality. The chronic 
inflammation that obesity is notorious for chronic inflammation and in this model chronic 
inflammation is hypothesized to modulate the sepsis (depicted in red) host response which 
results in an attenuated cytokine release and attenuated physical effect. Together the attenuated 
cytokine release and attenuated damage leads to lower mortality rates than in those individuals of 
normal weight. 
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 Discussion 
 The conceptual model presented here is a theoretical construct based on what is 
understood about pathophysiology and the reports of the obesity paradox in the literature.  This 
model offers a sound base upon which to test the salient variables of obesity, sepsis and 
mortality, but allows for adaptability to also test for associations between variables that will help 
to distinguish sepsis phenotypes.  For example, the relationships between obesity, demographic 
variables, biologic indicators of host response to infection, and degree of sepsis severity to the 
dependent variables of morality time points and long-term effects can be tested (Figure 4).  This 
is important in order to fully understand risk factors for individuals based on their unique 
phenotypical context.  
Figure 4 
This figure illustrates an example of how to use the proposed model to test relationships.  In 
this representation the base of the model remains constant, however different variables are added 
to further explicate potential relationships. This model tests the relationships between the 
independent variables of demographic information, obesity, biologic indicators of host response 
to infection, and sepsis severity with the dependent variables of mortality time points and long 
term effects.   
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An exploration of pathophysiology points to inflammation as the common characteristic 
shared by obesity and sepsis.  Molecular mechanisms demonstrate the immunometabolic actions 
of adipose tissue while also describing how the phenomenon of insulin resistance could apply in 
the case of hyperleptinemia.  Adipocytes produce the pro-inflammatory adipokine leptin and the 
pro-inflammatory cytokine IL-6, which are up regulated in obesity and sepsis, and leptin and IL-
6 independently promote the synthesis of CRP, a protein released during inflammation (Hribal, 
Fiorentino, & Sesti, 2014).  These same players are known to be elevated in obesity related 
insulin resistance, providing a physiologic precedence for receptor resistance (Figure 1) 
(D’Alessandris, Lauro, Presta, & Sesti, 2007; Osborn & Olefsky, 2012).  Leptin receptor 
resistance causes hyperleptinemia, whereby higher than normal leptin levels are present, but the 
leptin is biologically unavailable.  In other words, hyperleptinemia comes from a physiologic 
attempt to activate leptin receptors with increased leptin levels, causing the unexpected effect of 
an attenuated inflammatory response.  This modulated physiologic response seems to provide 
protection whereby, when both obesity and sepsis are present, the inflammatory response is 
attenuated rather than excessive, resulting in less tissue damage, less severe systemic response, 
and ultimately lower rates of severe sepsis, septic shock, and death (Hillenbrand, Knippschild, 
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Weiss, Schrezenmeier, Henne-Bruns, Huber-Lang, & Wolf, 2010).  Again, this conceptual model 
allows for the testing of these relationships to build upon the current body of knowledge (Figure 
4).  
Due to the serious nature of sepsis and its impact on the population, new theories are 
emerging and research into hypothesized sepsis etiologies  is underway.  The Persistent 
Inflammation, Immuosuppression, Catabolism Syndrome (PICS) hypothesis builds on the 
Chronic Critical Illness (CCI) model and attempts to define a phenotype of critical illness 
(Kamel, Rosenthal, Brakenridge, Croft, Moore, & Rosenthal, 2018). The main tenet is that given 
the excess energy stores in obesity, catabolism may not be as deleterious as it is in lean 
individuals.  The researchers state that further research is needed to control for increased 
adiposity.  This theory may offer an additional lens through which to view the complexity of 
sepsis mortality in obesity.  We propose that this theory does not negate the conceptual model 
presented in this paper.  Instead we agree that this theory has merit and could be tested within the 
model we propose.  
 The association between obesity and decreased sepsis mortality has been observed in 
several populations, yet the mechanism has not yet been fully described.  For example, increased 
BMI and decreased mortality has been documented in post-operative sepsis in vascular surgery 
(Davenport et al., 2009), laparoscopic gastric bypass, (Villamere, Gebhart, Vu, Nguyen, & 
Nguyen, 2014), sepsis from pneumonia (Corrales-Medina, Valayam, Serpa, Rueda, & Musher, 
2011; Kahlon et al., 2013; King et al., 2013; Nie et al., 2014; Reiner et al., 2009), and in septic 
shock (Arabi et al., 2013; Wacharasint et al., 2013).  While obesity puts patients at higher risk of 
contracting adult respiratory distress syndrome (ARDS) after surgery, the risk of mortality is 
lower (Memtsoudis et al., 2012).  It has been proposed that because obesity is associated with 
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less virulent gram positive infections such as from skin and soft tissue infection, the survival rate 
is higher. However, we suggest that obesity related chronic low-grade inflammation attenuates 
the host response resulting in lower mortality (Figure 3).  The variability in post-operative sepsis 
mortality could be related to pathogenic virulence in combination with obesity related 
inflammation modulation (Figure 3).  Sepsis from underlying respiratory causes, which are 
predominantly caused by virulent gram negative organisms, trends toward protection, with 
reduced 30 day mortality for obese patients with sepsis from pneumonia (Corrales-Medina, 
Valayam, Serpa, Rueda, & Musher, 2011; Kahlon et al., 2013; King et al., 2013; Nie et al., 2014; 
Reiner et al., 2009).  In septic shock obesity has been found to be associated with increased 
survival, indicating that the host response may be as important as microbial virulence when it 
comes to sepsis mortality (Arabi et al., 2013; Wacharasint et al., 2013).  However, the highly 
pathogenic H1N1 influenza was found to have higher 30 day mortality for obese patients with 
sepsis, which could be explained by the rapidity of the onset of illness associated with influenza, 
wherein an attenuated host response is not strong enough to halt its effects (Kwong, Campitelli, 
& Rosella, 2011).   
While several studies present contrary evidence on the association between obesity in 
adults and decreased sepsis mortality, we propose that methodological stringency and use of this 
conceptual model would help to strengthen interpretability of the results.  Gaulton et al. (2014) 
reported no difference in sepsis survival in obese individuals, but results stemmed from 
participants with presumed sepsis rather than confirmed sepsis, indicating individuals may not 
have had sepsis, severe sepsis or septic shock.  Papadimitriou-Olivgeris et al. (2016) reported no 
difference in sepsis survival in obese individuals when comparing sepsis outcomes to other 
critical illnesses such as intracranial hemorrhage, respiratory insufficiency, trauma, and a 
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category of “others.”  Comparing survival from sepsis to other critical illnesses with different 
pathophysiology is difficult to interpret and limits generalizability of the findings.  
Given the charge by the WHA (2017) to focus research and clinical practice on 
prevention, early diagnosis and treatment of sepsis, it is not surprising that sepsis treatment 
guidelines focus on advances in supportive care, source control, maintenance of hemodynamic 
stability, and anti-infective agents (Teng, Pourmand, & Mazer-Amirshahi, 2018).  Indeed, the 
Surviving Sepsis Campaign (2018) recommends measuring biologic indicators, such as serum 
lactate to guide treatment and the administration of anti-infective drugs after obtaining blood 
cultures.  Recently adjuvant targeted therapies such as activated protein C, toll like receptor 4 
antagonist, tumor necrosis factor receptor antagonist, and interleukin receptor antagonist, have 
been shown to be ineffective or harmful (Teng, Pourmand, & Mazer-Amirshahi, 2018).  Using 
the conceptual model described here to test relationships between the biologic indicators CRP, 
IL-6, and leptin may result in clinical practice changes, by providing a guide to risk stratification 
and early recognition or by providing a road map to reduce long term debilitation.  
An adjuvant approach that warrants investigation is the administration of leptin 
(metreleptin) to non-obese sepsis patients to simulate the immunomodulatory effect that obesity 
has in sepsis (Figure 3).  Currently leptin (metreleptin) is used to treat congenital leptin 
deficiency and lipodystrophy, but there is no Food and Drug Administration approval at this time 
for other uses (Blüher & Mantzoros, 2015).  A fear of using leptin in non-obese individuals 
relates to the orexigenic, or loss of appetite, effect that leptin is known for, which could reduce 
energy stores.  More research to better understand how exogenous leptin administration might 
affect non-obese individuals and sepsis mortality is needed.  
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Conclusion 
In both obesity and sepsis inflammation is the common thread.  While it may be unusual 
to describe the protective effects of obesity, it is important to acknowledge paradoxes in the 
human body that may converge to convey a benefit of obesity in sepsis survival.  Whether for 
risk stratification, phenotype identification, or for new treatment development, understanding the 
complexities of the obesity paradox is of primary importance.  The NINR explicitly cites 
symptom precursors, such as biologic indicators, as part of its strategic plan to determine 
symptom risk, disease severity, and disease duration (NINR, 2016).  This reinforces the 
importance of biologically focused research in nursing science to provide a strong foundation 
upon which to close knowledge gaps in patient care, such as has been identified in the obesity 
paradox.  
 Harnessing known biologic mechanisms is the basis of research that identifies possible 
new drug targets and classification of disease (Darden, Kundu, Pal, & Moult, 2018).  
Consideration of new ways to exploit biologic mechanisms is needed to advance patient care.  
Models that provide a basis for discovering causal factors of complex biologic systems such as 
sepsis are needed to set forth a road map for systematic investigation of variables that affect 
sepsis outcomes.  
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Abstract 
Sepsis is a life-threatening syndrome in which complex biologic systems respond to pathogenic 
invaders with pro- and anti-inflammatory responses in a manner that evolves over time, typically 
resulting in a dysregulated, or exaggerated host response (Singer et al., 2016).  A public health 
priority, sepsis affects 1.7 million adults and results in 270,000 deaths in the United States (US) 
annually (Centers for Disease Control and Prevention [CDC], 2016).  However, in recent years 
researchers have documented an “obesity paradox” where obese adults experience lower sepsis 
mortality than those with normal weight (Abbate, Perman, Clambey, Van Pelt, & Ginde, 2016; 
Arabi et al., 2013; Meyer et al., 2018; Nguyen et al., 2016; Wacharasint, Boyd, Russell, & 
Walley, 2013).  The majority of the literature describes the association between obesity and 
sepsis mortality in-hospital and at 30 days.  The single study that examined the obesity paradox 
at one year was limited to older adults, limiting generalizability to other age groups (Prescott, 
Chang, O’Brien, Langa, & Iwashyna, 2014).  The hypothesis central to this project is that the 
chronic inflammation of obesity attenuates the body’s response to the extreme inflammation seen 
in sepsis, resulting in a more balanced physiologic response that causes less endothelial damage, 
capillary permeability, organ dysfunction, and ultimately less death.  The problem is that our 
understanding of the obesity paradox in patients who survive sepsis at up to one year is very 
limited.  To address this gap, the primary research aim is to test whether the relationship between 
obesity and all-cause mortality at up to one year after sepsis holds true.  The secondary, 
exploratory aims of this project that will provide information for future work are to describe the 
relationships among demographic factors and biologic contributors linked to sepsis severity and 
outcomes within the context of obesity and mortality after sepsis.  Data from this project will be 
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used to increase understanding of the nature of the obesity paradox as a first step toward 
developing interventions to improve sepsis mortality. 
Specific Aims 
Despite extensive research, optimizing sepsis outcomes remains challenging.  Grim 
statistics indicate the magnitude of sepsis is far-reaching, with more than 1.7 million cases and 
270,000 deaths annually in the United States (US) (CDC, 2016), and an estimated 30 million 
cases and 6 million deaths per year globally (Reinhart, Daniels, Kissoon, Machado, Schachter, & 
Finger, 2017).  Due to recent advances in early sepsis recognition and treatment, more people 
survive the initial insult, yet many experience persistent residual symptoms of physical, 
psychological, cognitive and functional frailty, as well as late mortality (Gardner et al., 2019; 
Iwashyna & Netzer, 2012; Winters et al., 2010).  The literature primarily examines sepsis 
outcomes in the short term, omitting endpoints that may better estimate the long-term effects, 
despite the Surviving Sepsis Campaign call for new research to describe predictors of sepsis 
long-term morbidity and mortality as a top priority (Coopersmith et al., 2018).  Precedence for 
the obesity paradox in inflammatory conditions (Braun et al., 2017; De Schutter et al., 2016; 
Hafner, Hillenbrand, Knippschild, & Radermacher, 2013) and for short term sepsis mortality 
(Abbate et al., 2016; Arabi et al., 2013; Meyer et al., 2018; Nguyen et al., 2016; Sakr et al., 2013; 
Wacharasint et al., 2013) has been established.  What is not well understood is the effect of 
obesity on long term sepsis outcomes.  The demographic variables of age, sex, and race have 
been shown to affect mortality in the general population of sepsis patients. However, the 
relationship between these variables with obesity and mortality after sepsis has not yet been fully 
explored. 
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Similarly, biomarkers that indicate sepsis and severity, such as white blood cells (WBC), c-
reactive protein (CRP), and lactate, have not yet been examined in the context of obesity and 
mortality after sepsis.  It is expected that distinctive differences between obese and non-obese 
physiologic states will be associated with varied sepsis outcomes.  Descriptive research of this 
nature is the first step toward understanding the relationships of the above variables and their 
contributions to sepsis outcomes.  Once these relationships are better understood, future research 
can focus on understanding causative factors that contribute to decreased sepsis mortality and 
thereby guide the development of future interventions.  
In this descriptive study we aim to interrogate existing data from administrative and 
medical record databases at a large academic medical center, 
Aim 1:  To examine the relationship between body mass index (BMI) and mortality at 30 days, 
180 days, and 1 year after sepsis diagnosis in adults age 18 and older.  A sub-aim is to examine 
the relationship between BMI and mortality at 30 days, 180 days, and 1 year after sepsis 
diagnosis in adults age 18 and older with sepsis severity (sepsis, severe sepsis, septic shock). 
Hypothesis:  BMI > 30 (obesity) is associated with lower mortality in adults at 30 days, 180 
days, and 1 year after diagnosis, and BMI may be associated with sepsis severity.  
R1:  What is the relationship between BMI and mortality at the time points 30 days, 180 days, 
and 1 year one year after sepsis in adults age 18 and older?  
R2:  What is the relationship between BMI and mortality after sepsis at the same time points, 
stratified by severity of sepsis (sepsis, severe sepsis, septic shock)? 
Aim 2:  To describe the relationship between the demographic variables (sex, age, race) and 
biologic variables (CRP, WBC, lactate) with BMI and mortality at 30 days, 180 days, and 1 year 
after sepsis diagnosis in adults age 18 and older. 
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Hypothesis:  BMI, demographic characteristics, and biologic variables are potential confounding 
variables affecting mortality in adults at 30 days, 180 days, and 1 year after diagnosis.  
R3:  What is the relationship between BMI categories and mortality after sepsis at the same time 
points, by demographic variables (age, sex, race)? 
R4:  What is the relationship between BMI categories and mortality after sepsis at the same time 
points, by biological factors (WBC, CRP, lactate)? 
Significance 
Sepsis and obesity have high incidence and mortality rates independent of each other.  
When taken together, one might expect a perfect storm in which patient outcomes are 
exponentially worse than either diagnosis on its own.  This notion is countered by the “obesity 
paradox” where obese individuals with sepsis survive at higher rates than non-obese individuals 
in the short term (Abbate et al., 2016; Arabi et al., 2013; Meyer et al., 2018; Nguyen et al., 2016; 
Sakr et al., 2013; Wacharasint et al., 2013). 
Obesity is a global epidemic associated with complex multi-system diseases affecting 
cardiovascular, endocrine, and mental health, and increased all-cause mortality (Keaver, Xu, 
Jaccard, & Webber, 2018).  Complications of obesity can potentiate each other, such as type 2 
diabetes and hypertension leading to chronic kidney disease.  The physiologic consequences of 
obesity increase the risk of complications and the likelihood of slowed recovery from sepsis.  
However, when they co-occur, sepsis and obesity are associated with better rather than worse 
survival in the short term, observations that have collectively been described as the “obesity 
paradox.”  Inconsistent results on the impact of obesity on other critical illnesses have indicated 
that obesity may be related to better, worse, or unchanged rates of hospital and intensive care 
unit (ICU) length of stay and mortality (Martino et al., 2011).  Narrowing the scope of 
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investigation from critical illness to sepsis will be pivotal to establish relationships among 
variables affecting mortality and to identify a phenotype of sepsis survivors.  Given the 
implications of the obesity paradox in the short term and the resultant chronicity of sepsis 
following survival, the main objective is to describe the association of obesity and mortality at 30 
days, 180 days and at 1 year in adults after sepsis. 
Theoretical Framework 
The central concepts involved in the conceptual framework for this project are 
inflammation, obesity, and sepsis.  Each concept and their interactions are described below.  
Obesity 
Characterized by excess adipose tissue, obesity is a global health concern that increases 
the risk of comorbidities, decreases life expectancy, and results in 2.8 million deaths annually 
(Pal, Pal, Babu, & Lalitha, 2015).  Antecedents of obesity include caloric energy intake and 
usage imbalance, decreased physical activity, and genetic predispositions (Pal et al., 2015).  
Recent observations point to socioeconomic status and environmental factors causing epigenetic 
modifications as well (Vecchié et al., 2018).  Obesity is associated with several disorders such as 
metabolic syndrome, type 2 diabetes, cardiovascular disease, lipid disorders, stroke, sleep apnea, 
and cancer (CDC, 2018).  In the US, middle-aged (40.2%) and older adults (37%), as well as 
non-Hispanic blacks (48.1%) and Hispanics (42.5%), have higher rates of obesity than other 
groups (CDC, August 13, 2018).  The economic burden of obesity was estimated at $147 billion 
in the US in 2008 (CDC, August 13, 2018). 
Obesity definition. 
Obesity has been defined as an accumulation of abnormal or excessive fat that is a risk to 
health (WHO, 2019) and as a chronic disease with multiple phenotypes where excess adiposity 
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leads to physiologic abnormalities (Kelly, Kahan, Heymsfield, Kotz, & Jastreboff, 2019).  
Obesity is a clinical diagnosis that is determined by the surrogate measure of body fat, BMI, an 
index of weight adjusted for height that only indirectly estimates body fat.  A limitation of BMI 
is that individuals with varying clinical and biochemical characteristics are categorized similarly, 
regardless of emerging evidence of obesity phenotypes (Vecchié et al., 2018).  Despite this 
limitation, BMI is still accepted internationally by researchers as the standard method for 
identifying and defining obesity (Engin, 2017). 
The consequences of obesity stem from heightened endocrine activity that occurs when 
there is excess adipose tissue.  Chronic low-grade inflammation occurs when macrophages take 
up residence in adipose tissue causing dysregulation of cytokines IL-6, CRP, and TNF-α, while 
parallel down regulation of the anti-inflammatory adipokine adiponectin and up regulation of the 
pro-inflammatory adipokine leptin occurs (Cottam et al., 2004).  As in acute inflammation, 
neurophysiologic control of energy balance and regulation of body weight occurs along the HPA 
axis.  Specifically, obesity states can impair neuronal function that can alter homeostatic 
feedback loops, compounding inflammatory modulation (Pal et al., 2015).  Chronic low-grade 
inflammation increases pro-inflammatory cytokines, while alteration in the HPA axis increases 
catecholamine and glucocorticoid levels that together contribute to the modulation of immune 
function (Pal et al., 2015), see Figure 1. 
Figure 1 
Hypothesized relationships between HPA dysregulation and obesity-associated factors: The 
hypothalamus-pituitary-adrenal (HPA) axis becomes dysregulated in obese states where 
heightened endocrine activity causes chronic low-grade inflammation resulting in chronically 
interleukins, tumor necrosis factor-alpha, and c-reactive protein. The anti-inflammatory 
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adipokine adiponectin is decreased contributing to decreased insulin sensitivity and insulin 
resistance. It is hypothesized that the pro-inflammatory adipokine leptin is increased due to leptin 
receptor resistance, which is related to and contributes to insulin resistance, and taken together 
result in inflammatory modulation. Adapted from Pal et al., (2015). 
 
 Inflammation 
The body is an integrated system that uses inflammation to communicate exposure to 
foreign substances, tissue damage, or pathogen invasion (Bennett, Reeves, Billman, & 
Sturmberg, 2018; Del Giudice & Gangestad, 2018).  Governed by immune-regulatory pathways, 
the sympathetic nervous system (SNS) triggers peripheral pro-inflammatory responses, while the 
parasympathetic nervous system (PNS) and the neuroendocrine hypothalamic-pituitary-adrenal 
(HPA) axis balance sympathetic effects by inhibiting inflammatory responses.  These pathways 
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are mediated by cytokine and hormonal influences in healthy or “normal” inflammatory 
responses (Bennett et al., 2018), see Figure 2.  At the intersection of the immune and 
neuroendocrine systems, cytokines and immune mediators released during the immune response 
activate neural responses that exaggerate local inflammation, and that enable neuroendocrine 
responses to restore homeostasis (Bennett et al., 2018). 
Figure 2 
 
The normal immune response: consists of immune regulatory pathways that govern peripheral 
sympathetic pro-inflammatory responses as well as peripheral parasympathetic and 
neuroendocrine anti-inflammatory responses to elicit a balanced inflammatory response, adapted 
from Bennett et al. (2018).  
 
The ubiquitous goal of non-specific inflammation is to increase blood flow, dispatch 
white blood cells to infiltrate the area and contain the threat, followed by phagocytosis to remove 
the threat. When the body is invaded or injured, pathogen-associated molecular patterns 
(PAMPs) and damage-associated molecular patterns (DAMPs), respectively, lead to activation of 
the inflammatory system where monocyte-macrophage cells are released, followed by the release 
of cytokines and chemokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-
α), that mediate non-specific cellular, tissue, and vascular damage (Bennett et al., 2018; Del 
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Giudice & Gangestad, 2018).  Meanwhile, CRP, a protein released during inflammation, is 
upregulated due to the abundance of monocytic cells and IL-6.  Normally, this process is 
followed by down-regulation of inflammation to promote healing and maintain homeostasis 
(Bennett et al., 2018).   
Sepsis 
Sepsis is a heterogeneous syndrome where a dysregulated host response to infection 
occurs in response to widespread inflammation (Cohen et al., 2015).  In patients with sepsis 
without organ dysfunction, the mortality rate is less than 20%, whereas in those with organ 
dysfunction mortality has been reported as over 50% (De La Rica, Gilsanz, & Maseda, 2016).  
Mansur et al. (2015) reported a 71% increase in cases of severe sepsis between 2003 and 2007 
and reported that total costs for all patients with severe sepsis increased 57% in the same period.  
The approximate cost of sepsis care in 2008 was $14.6 billion (Hall, Williams, DeFrances, & 
Golosinskiy, 2011). 
The risk factors for sepsis are varied.  More than half of the cases of severe sepsis occur 
in adults over age 65 (Mayr, Yende, & Angus, 2014).  Sepsis is more common in males (De La 
Rica et al., 2016; Sakr et al., 2012) and blacks versus whites (Barnato, Alexander, Linde-
Zwirble, & Angus, 2008; Dombrovskiy, Martin, Sunderram, & Paz, 2007).  De La Rica and 
colleagues (2016) found that in the US, African Americans had a 2-fold higher probability of 
experiencing sepsis.  Over half of the patients with sepsis have chronic comorbid conditions such 
as diabetes, congestive heart failure, chronic pulmonary disease, cancer, and chronic renal failure 
(De La Rica et al., 2016; Mayr et al., 2014). 
Sepsis definition. 
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While systemic inflammatory response syndrome (SIRS) has been the focus of sepsis 
research for the last two decades (Bone et al., 1992; Levy et al., 2003), a refined understanding 
of the pathophysiology now points to an altered host response as the underlying cause of sepsis 
(Singer, Deutschman, Seymour, Shankar-Hari, et al., 2016).  The new “Sepsis-3” definitions 
suggest removal of the diagnosis of “severe sepsis” from the lexicon (Singer et al., 2016) despite 
this term differentiating the phenotype and its use over the past two decades in International 
Classification of Disease, ninth edition (ICD-9) coding. 
Sepsis pathophysiology. 
When the body encounters a pathogen, an inflammatory and immune response occurs in 
an attempt to isolate the threat.  If not contained, the pathogen can result in infection and the 
immune response will trigger the release of leukocytes to systemically counteract the pathogen in 
an attempt to recover.  However, in some cases the inflammatory response is over-zealous, 
leading to the excessive inflammation that causes epithelial damage, increased capillary 
permeability, organ dysfunction, and even death (Winters et al., 2010), see Figure 3.   
Figure 3 
Comparison of biomarker changes in healthy normal versus dysregulated immune 
responses: The normal immune response from threat to infection, diagrammed left to right, 
consists of a balanced effect of acute inflammation, cellular immunity and physiologic response 
to infection. In sepsis, in red, the host response becomes over-zealous resulting in a cytokine 
storm that causes epithelial damage, increased capillary permeability, organ dysfunction, and 
sometimes death. 
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Sepsis Diagnosis. 
Rapid identification of sepsis includes assessing patient presentation along with 
laboratory markers to assist in determining disease severity and prognosis (Fan, Miller, Lee, & 
Remick, 2016).  CRP levels reflect the degree of inflammation and disease severity (Gradel, 
Jensen, Kolmos, Pedersen, Vinholt, & Lassen, 2013).  WBC levels indicate immune system 
activation due to a pathogen (Castelli, Pognani, Cita, Stuani, Sgarbi, & Paladini, 2006).  Lactate 
is measured to identify the degree of hypoperfusion present and as a prognostic marker, where 
elevated levels indicate more severe disease and a higher likelihood of mortality (Anderson, 
Mackenhauer, Roberts, Berg, Cocchi, & Donnino, 2013). 
Relationship between obesity and sepsis 
Inflammation is the common pathway shared by obesity and sepsis.  In obesity, up-
regulation of the pro-inflammatory markers IL-6, CRP, and leptin, along with down-regulation 
of the anti-inflammatory marker adiponectin, leads to chronic inflammation (Singer & Granger, 
2007).  It is hypothesized that in obese individuals where there is chronic inflammation, the 
excessive inflammation of sepsis causes less endothelial damage and organ dysfunction, and 
results in lower mortality, see Figure 4.  While all the variables in the conceptual model merit 
study, some data were not available to fully examine these inflammatory processes 
retrospectively.  Therefore, future prospective studies will be undertaken to further explore these 
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variables in more detail.  Nevertheless, one advantage of this hospital-based dataset is that WBC 
and lactate, both indicators of disease severity, and CRP, an important marker of inflammation, 
were available.  Therefore, these biomarkers and their associations with mortality and BMI will 
be included in the statistical analyses for this proposed research, see Figure 4b.  
Figure 4 
 
The Hypothesized relationship between obesity-related factors and sepsis mortality: In blue, 
the chronic inflammation of obesity, with upregulated pro-inflammatory adipokines (leptin), 
interleukins, tumor necrosis factor-alpha, and c-reactive protein modulate the effect of sepsis, in 
red. The result is a modulated, rather than over-zealous, host response that results in lower 
mortality. 
 
Figure 4b 
Variables included in this research.  The main association between obesity, measured by BMI, 
and sepsis mortality after one year, will be examined.  The relationships between demographics 
(age, sex, race) with obesity and mortality at one year after sepsis will be examined.  
Additionally, the relationships between markers of inflammation and/or sepsis (CRP, WBC, 
lactate) with obesity and mortality at one year after sepsis will be examined.   
78 
 
 
Study Design 
A retrospective cohort study was designed to examine the primary endpoint of mortality 
at up to one year after sepsis diagnosis and to compare characteristics of individuals by BMI.  To 
determine the feasibility and availability of data on the variables of interest three databases were 
examined.  First, the Medical Information Mart for Intensive Care, 3rd edition (MIMIC-III) 
database, which integrates deidentified, clinical data of patients admitted to the Beth Israel 
Deaconess Medical Center in Boston, Massachusetts was examined for the presence of the 
variables of interest (Johnson et al., 2016).  Next, the Virginia Commonwealth University (VCU) 
Center for Clinical and Translational Research (CCTR) was consulted, resulting in the 
examination of the TriNetX database and the electronic health record and administrative billing 
database of VCU were to determine the availability of biomarker data.  While none of the 
databases had biomarker data for infrequently ordered clinical tests such as leptin and IL-6, the 
VCU database contained sufficient numbers of some markers of inflammation and infection 
(WBC, lactate, and CRP).  Demographic variables, BMI, and laboratory data were obtained from 
the electronic health record, while the administrative database was used to identify admission 
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dates and diagnosis codes.  The administrative database was matched to the Social Security 
Administration (SSA) Death Master File by the data analyst at the academic medical center to 
identify dates of death.  The primary aim of this proposal is to examine the relationship between 
obesity and mortality at 30 days, 180 days, and at 1 year after sepsis diagnosis in adults over age 
18.  The secondary aims are to describe the relationships between the outcomes in Aim 1 with 
age, sex, and race, and with WBC, lactate, and CRP.  The 30-day time point is necessary to 
compare results of this study with findings from the literature showing a protective effect of 
obesity on mortality, while the 180 day and 1-year time points will enable exploration of the 
longevity of protection ascribed to obesity on mortality after sepsis.  Institutional Review Board 
approval has already been received (IRB-hm20010673_ame) for this project and was determined 
to be exempt. 
Sample 
A convenience sample comprised of adults age 18 and older with one or more diagnoses 
of sepsis within the years 2007- 2018 was identified (N = 11,981).  Sepsis was identified using 
ICD-9 codes.  Individuals were identified initially by medical record number (MRN), date of 
birth (DoB), and date of admission, and then anonymized by the primary investigator, by 
organizing the data by descending MRN, assigning a consecutive number beginning with “1” to 
each record and removing all identifiers.  Dates of admission, discharge, and death will be 
retained for subsequent research that is in alignment with the aims of this study.  Records 
without BMI will not be included, n = 6,216, and only the first admission for a diagnosis of 
sepsis will be included in the study, resulting in n = 4,756 to be used for analysis.  Laboratory 
data reported below the detectable limit (i.e., < X) were imputed.  Results will be reported in 
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aggregate to eliminate the possibility of identifying an individual point or combination of data 
points. 
Data collection, cleaning, and storage 
Data were received from the academic medical center data analyst in a password 
protected encrypted Excel file via the Research Electronic Data Capture (REDCap) hosted by the 
Virginia Commonwealth University (VCU).  The data were subsequently parsed by the 
identifiers of medical record number (MRN), date of birth (DoB), and date of admission (DoA).  
The Excel add-in extension Ablebits was used to merge data across spreadsheets together using 
the MRN as the match-point.  Each variable was merged onto one spreadsheet using an exact 
date match to the date of admission.  To complete the data merge hand-sorting of data for the 
variables was conducted to include all data points that occurred 1 day before the admission date 
and up to 5 days after the admission date.  To meet the statistical assumption of independence 
among the observations the data were further parsed by MRN and DoA to identify if more than 
one admission existed for an MRN.  The Ablebits "Quick Dedupe" option was used to select 
"MRN" and "move to a new worksheet."  This action transferred 2,685 rows of data to a new 
workbook and left only the first DoA for each MRN.  The remaining 9,296 unique rows of data 
were filtered largest to smallest, and a unique identification number was assigned.  A master list 
with patient identifiers is kept in a password-protected external hard drive that is stored in a 
locked file cabinet in the office of the primary investigator.   
Measures 
Obesity:  BMI will be used to categorize individuals based on height and weight.  BMI 
was collected in the EHR as a continuous variable, and for this project, BMI will be categorized 
into the WHO BMI classifications (2019).   
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Sepsis:  Individual records were identified using the ICD-9 diagnosis codes related to infection, 
sepsis, and systemic inflammatory response syndrome, see Table 1.  Only records with a 
diagnosis code for sepsis (785.52; 995.91; 995.92) will be included in the analysis. 
Mortality:  To compute all-cause mortality overall survival reported in days will be 
examined where all-cause mortality may include death from sepsis, from co-morbidities, or some 
unknown cause.  Despite this limitation, this is an essential first step toward describing mortality 
rates at up to 1 year after sepsis.  Mortality time points will include the time period of the date of 
admission and the end-point(s) will be 30 days, 180 days, and 1-year after sepsis diagnosis.  The 
SSA Death Master file was queried in 2019 for the dates of 2007-2018 to ensure that if death 
occurred within 1 year 2018 that death date was included.   
Data Point Definitions 
• Date of admission: This is the date the individual was admitted to the academic medical 
center. 
• Date of death: This is the date of individual death identified by the SSA Death Master 
File. The cause of death is not identified within this dataset. This limitation will be 
reported.   
• Age:  DoB was used to identify individuals’ age at the time of admission and time of 
death.  DoB was removed from the dataset using the anonymization procedure described 
previously.  Records for individuals under the age of 18 were excluded. 
• Sex:  Sex is reported by the individual as either male or female and is recorded in the 
medical record at the academic medical center.  There is a risk that this data is entered 
incorrectly, potentially affecting results.  This limitation will be reported. 
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• Race:  Race is reported by the individual and recorded in the EHR at the academic 
medical center.  There is a risk that this data is entered incorrectly, potentially affecting 
results. This limitation will be reported. 
• BMI:  BMI was recorded in the EHR as a continuous variable, but will be collapsed into 
WHO categories as follows:  < 18.5 Underweight; 18.50-24.99 Normal Weight; ≥ 25.00 
Overweight;  ≥ 30.00 Obese.  Further stratification of these classifications are as follows:  
< 16 Severe thinness; 16-16.99 Moderate thinness; 17-18.49 Mild thinness; 25- 29.99 
Pre-obese; 30 – 34.99 Obese Class I; 35-39.99 Obese Class II; ≥ 40.00 Obese Class III 
(WHO, 2019). BMI distribution of this subset ranged from 10.47 to 84.72; BMI < 14 (n = 
15) will be excluded from the analysis. 
• Biomarkers. Sepsis is a syndrome without a specific test to confirm its presence.  The use 
of several biomarkers together, along with physical examination, is the standard for 
diagnosing sepsis.  Diagnostic features suggestive of sepsis include elevated WBC, CRP, 
and lactate.   
o White blood cells (WBC):  WBCs can be elevated for several systemic 
indications; however, a count >12,000/mm3 or <4,000/mm3 is one parameter of 
several that indicates sepsis.  Data reported as less than the detectable limit was 
imputed by dividing the reported value by 2 and using the subsequent value (i.e., 
< 0.1/2 = 0.05). 
o Lactate is a marker of endogenous catecholamines.  Lactate levels equal to or 
greater than 2 mmol/L at presentation is indicative of hypoperfusion, such as in 
septic shock, and decreasing or normalized lactate levels indicate recovery 
(Gomez & Kellum, 2015).  
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o CRP is an acute-phase reactant that is frequently elevated in acute inflammation, 
and though not specific for sepsis CRP can indicate sepsis severity.  Data reported 
as less than the detectable limit was imputed by dividing the reported value by 2 
and using the subsequent value (i.e.: < 0.3/2 = 0.15), with the exception of a value 
reported as < 31.7, which was kept in the dataset as 31.7 since this is an elevation 
from normal that is biologically plausible.  
Inclusion and Exclusion Criteria 
BMI is a required study variable; therefore, only patients with BMI information were 
included (n = 6,216).  Values for BMI, WBC, lactate, and CRP were included if recorded within 
the time period of 1 day before the admission date and 5 days after the admission date.  BMI 
values of < 14 and > 90 will be excluded from analysis a priori to reduce the inclusion of 
possible spurious values and to reduce the likelihood of extreme BMI values biasing the results.  
Medical records with BMI not recorded within the time period of 1 day before the admission 
date and 5 days after the admission date were excluded.  
Missing Data 
Missing data is a known challenge in the use of electronic health records for research.  
The patterns of missingness are generally considered to be missing at random (MAR) rather than 
missing completely at random (MCAR).  To handle the missing data in this dataset the method 
of listwise deletion will be used, whereby only observations with complete data will be used for 
analysis (Raghunathan, 2004; Meeyai, 2016).  This method has been reported to be robust in 
regression analysis even when violations of MCAR or MAR may exist for the predictor 
variables, given that the missingness does not depend on the dependent variable.  The risks of 
listwise deletion include potential Type II error and potential for bias, though the loss of 
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statistical power is unlikely in large datasets (Raghunathan, 2004; Meeyai, 2016).  Other 
methods for handling missing data, such as mean substitution and regression imputation, were 
considered and deemed unsuitable due to loss of accuracy in the data. 
Data Density   
For the time period of 2007 to 2018, N = 11,981 admissions for sepsis were identified.  
Each of these was matched with the SSA Death Master File. A total of n = 6,216 had data for 
BMI.  From this sample, the first admission for a diagnosis of sepsis will be included in the 
study, resulting in n = 4,756 to be used for analysis. Next, the total number of observations with 
age, sex, and race is n = 4,709. Lastly, the total number of observations with CRP, WBC, and 
Lactate is n = 210. 
Total observations with sepsis diagnosis and death date N = 11,981 
+ BMI       n  =  6,216 
+ Restricted to first sepsis diagnosis   n  =  4,756 
+ Age, Sex, Race     n  =  4,709 
+ CRP, WBC, Lactate    n  =  210 
Statistical Plan:   
A quantitative study using logistic regression will be conducted to analyze the 
relationships among the variables and their ability to predict the likelihood of the dichotomous 
dependent variable of mortality (alive vs. dead) at the three-time points identified.   
Descriptive Statistics  
The data, from a sample of individuals with a diagnosis of sepsis, will be examined 
descriptively and graphically.  For continuous variables, distributions will be assessed with 
histograms and outlier box plots, and the means and standard errors will be calculated and 
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reported in tabular form.  For categorical variables, frequencies and percentages will be 
calculated and reported in tabular form.  Further, the means with standard deviations and 
frequencies with percentages will be presented for BMI <30 (not obese) and ≥ 30 (obese) and 
pooled to initially describe the data.  
Logistic Regression Models 
Logistic regression will be used to build prediction models using the method proposed by 
Hosmer and Lemeshow (2013).  In this analysis, three dependent variables defined by time (30 
days, 180 days, and 1 year) for which logistic regression will be used to assess the effect of BMI 
by category on mortality.  Thus, the analysis steps that follow will apply to each of the dependent 
variables.  
Assumptions for logistic regression include a binary dependent variable, independence 
among the observations, linearity in the logit for continuous predictors, and no multicollinearity 
among the predictors.  Finally, it assumed that the sample size is sufficient as defined by n = 100 
+50i, where i is the number of predictor variables (Bujang, Sa’at, Tg, Sidik, & Lim, 2018).  The 
assumption of linearity of the logit for continuous predictors, i.e., age, will be tested by forming 
three design variables based on quartiles of age.  The linearity assumption is satisfied if the 
ordered logits are linear.  
Steps to Model Building  
Step 1:  Using the model-building strategy proposed by Hosmer and Lemeshow (2013), 
the first step is to explore bivariate associations between the independent variable and each of the 
dependent variables using simple logistic regression.  A p-value cut off of < 0.25 will make that 
predictor eligible for the multiple regression model in the next step. 
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Step 2:  In the second step, a multivariable model will be formed using all variables, as 
identified in the first step.  
Step 3:  Variables with a p-value > 0.05 will be eliminated from the model one at a time 
using a backward stepwise approach, with the least significant variable being removed first. 
Step 4:  Interactions between the remaining main effects will be added to the model in 
Step 2.  Only interactions deemed of clinical interest will be added in this step.  It is anticipated 
that interaction terms of WBC and lactate; lactate and CRP; age and disease severity; and lactate 
and disease severity will be of clinical interest. 
Step 5:  Similar to the approach in Step 2, a backward stepwise approach will be used to 
remove those interactions with a p-value > 0.05.  
The resultant model from Step 5 will be considered the final predictive model. Note that this 
process will be used three times; one for each dependent variable defined above.  Data analysis 
will be completed on JMP Pro version 14.2.0 (64-bit). 
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Abstract 
Sepsis is a serious and life-threatening syndrome affecting 1.7 million Americans annually and 
resulting in approximately 270,000 deaths.  An “obesity paradox” where obese individuals have 
lower sepsis mortality than their non-obese counterparts has been described. The problem is that 
the longevity of the effect is unknown, and few studies have examined the obesity paradox after 
1-2 months post-diagnosis.  Therefore, this retrospective cohort study examined clinical, 
demographic, and biomarker variables thought to affect sepsis mortality at three-time points: 30 
days, 180 days, and one year in order to shed light on specific factors that might define a “sepsis 
survivor” phenotype.  A convenience sample of adults age 18 and older admitted to an academic 
medical center between the years of 2007 to 2018 with a diagnosis of sepsis was identified.  
Simple logistic regression was used to test for significance between age, sex, race, c-reactive 
protein, lactate, white blood cells, body mass index, and sepsis severity on mortality at each of 
the three previously described time points.  Variables with statistical and clinical significance 
were entered into multivariate logistic regression models to explore the contributions of each 
variable and interactions between variables at 30 days, 180 days, and one year.  We found for 
every 5 unit increase in BMI, the odds of mortality are 0.92 (95% CI: 0.85, 0.99) times lower at 
30 days since sepsis diagnosis.   However, at 180-day and one-year post sepsis diagnosis, as BMI 
increased, there was an increase in odds of death for each sepsis type.  In this dataset, it appears 
that the "obesity paradox" exists up to 30 days, but the protective effect of obesity on sepsis 
outcomes may not extend beyond one month. 
   Keywords: Sepsis, Obesity, Mortality, Body Mass Index 
  
97 
 
Examining Body Mass Index and Mortality at One Year After Sepsis 
Sepsis is a serious and life-threatening syndrome affecting 1.7 million Americans 
annually, resulting in approximately 270,000 deaths (Centers for Disease Control and Prevention 
[CDC], 2016).  In recent years early detection and treatment of sepsis have been a priority for 
clinicians and researchers (De Backer & Dorman, 2017).  Recent data suggests that now more 
people are surviving the initial sepsis diagnosis, and in those individuals, residual symptoms of 
physical, psychological, cognitive and functional frailty, and late mortality persist (Gardner et 
al., 2019; Iwashyna & Netzer, 2012; Winters et al., 2010).  Indeed, research to describe 
predictors of sepsis long-term morbidity and mortality has been identified as a top priority by the 
Surviving Sepsis Campaign (Coopersmith et al., 2018) and the World Health Assembly 
(Reinhart et al., 2017). 
Obesity is a condition known to cause deleterious health consequences (Keaver et al., 
2018).  Nevertheless, when obese individuals experience sepsis, they have better short-term 
survival rates, which has been described as the “obesity paradox,” referring to the ostensible 
protective effect of obesity (Abbate et al., 2016; Arabi et al., 2013; Meyer et al., 2018; Nguyen et 
al., 2016; Wacharasint et al., 2013).  Not unique to sepsis, the obesity paradox has been reported 
in other in inflammatory conditions, such as pneumonia, coronary artery disease, and acute 
kidney injury (Braun et al., 2016; De Schutter et al., 2016; Hafner et al., 2013).  The problem is 
that few studies to date have explored the duration of the obesity paradox in sepsis after 1-2 
months and certainly not out to one year (Li et al., 2019; Pepper et al., 2019; Prescott et al., 
2014).  Describing the relationships between variables that affect sepsis outcomes and exploring 
the magnitude of long-term mortality is essential in order to develop interventions, given the 
documented chronicity of symptoms in sepsis survivors (Iwashyna & Netzer, 2012). 
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The physiologic basis for the advantage of obesity in sepsis is unclear.  However, the 
hypothesis central to this project is that the chronic inflammation of obesity attenuates the body’s 
response to the extreme inflammation seen in sepsis, resulting in a more balanced physiologic 
response that causes less endothelial damage, capillary permeability, organ dysfunction, and 
ultimately lower mortality.  The theoretical framework for testing the relationship between 
obesity and sepsis mortality has been described elsewhere (Robinson, Swift-Scanlan, Salyer, & 
Jones, 2020).  
Other variables purported to impact sepsis outcomes are demographic and biological 
factors.  For example, associations of sex, age, and race have been described in the short-term, 
but not the long-term, after sepsis.  Biomarkers such as white blood cells (WBC), c-reactive 
protein (CRP), and lactate are useful in diagnosing infection, inflammation, and septic shock, 
respectively, but have not yet been examined as potential predictors of long-term survival in the 
context of obesity and mortality after sepsis.  It is expected that distinctive differences between 
obese and non-obese physiologic states are associated with varied sepsis outcomes.   
This research project was designed to address the dearth of knowledge about obesity and 
long-term sepsis mortality.  The aim was to test whether the relationship between increased body 
mass index (BMI) and all-cause mortality at 30 days, 180 days, and up to one year after sepsis 
remains protective.  We explored the interactions between BMI and sepsis severity at each time 
point.  Additionally, we tested the relationships between demographic variables (sex, age, race) 
and biologic variables (CRP, WBC, lactate) with BMI and sepsis mortality at 30 days, 180 days, 
and one year after sepsis diagnosis in adults age 18 and older.  The hypothesis is that BMI, 
demographic characteristics, and biologic variables are potential contributing factors affecting 
mortality in adults at 30 days, 180 days, and one year after diagnosis. 
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Methods 
A retrospective cohort study was designed to examine factors affecting mortality at 30 
days, 180 days, and one year.  Through a partnership with the C. Kenneth and Dianne Wright 
Center (Center for Clinical and Translational Research [CCTR], 2020) data were collected from 
the electronic health record and the administrative database of a tertiary care academic medical 
center for a ten year period.  Demographic variables, BMI, and laboratory data were obtained 
from the electronic health record.  Admission dates and diagnosis codes were collected from the 
administrative database, which was matched to the Social Security Administration Death Master 
File to identify dates of death.  
Data were cleaned by merging each variable into one spreadsheet using an exact date 
match to the date of admission.  Hand-sorting of the variables was conducted to include all data 
points that occurred one day before the admission date and up to 5 days after the admission date.  
Listwise deletion was used to handle missing data.  The data were then parsed by medical record 
number (MRN) and date of admission (DoA) to identify if more than one admission existed for 
an MRN, and if so, only the first date of admission was used to satisfy the assumption of 
independence between observations.  Each MRN included was then assigned a unique 
identification number and de-identified in the analysis file.  Data were secured in a password 
protected encrypted Excel file via the Research Electronic Data Capture (REDCap) platform 
hosted by Virginia Commonwealth University (VCU) (CCTR, 2020).  Institutional Review 
Board approval was obtained for this study.  
Sample.  
A convenience sample of adults age 18 and older admitted to the academic medical 
center between the years of 2007 to 2018 with a diagnosis of sepsis was identified (N = 11,981). 
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Only the first admission for a diagnosis of sepsis was included in the study, and records without 
BMI were excluded (n = 4,756).  Laboratory data reported below the detectable limit (i.e., < X) 
were imputed.  WBC reported as less than the detectable limit was imputed by dividing the 
reported value by two and using the subsequent value (i.e., < 0.1/2 = 0.05).  CRP reported as less 
than the detectable limit was imputed by dividing the reported value by two and using the 
subsequent value (i.e., < 0.3/2 = 0.15), except for a value reported as < 31.7, which was retained 
based on the rationale that this value is an elevation from normal that is biologically plausible.  
Results were reported in aggregate.   
Inclusion and Exclusion Criteria.  To ensure that the values for BMI, WBC, lactate, 
and CRP were captured as close as possible to the time of sepsis diagnosis, values were included 
if they were recorded within one day before the admission date and five days after the admission 
date.  BMI values of < 14 and > 90 kg/m2 were excluded from analysis a priori to reduce the 
inclusion of possible spurious values and to reduce the likelihood of extreme BMI values biasing 
the results. BMI in this dataset was recorded by the pharmacy. Medical records with BMI not 
recorded within the time period of 1 day before the admission date and five days after the 
admission date were excluded.  WBC values > 30,000 cells/mm3 were excluded to reduce the 
chance of inclusion of conditions other than sepsis (Widick & Winer, 2016).  Lactate values > 6 
mmol/L were excluded due to small numbers in that range.  Race other than white non-Hispanic 
and black non-Hispanic were excluded due to small sample size.  For the study flow diagram, see 
figure 1. 
Variables 
The variables included in the study were defined as follows:  
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• Sepsis was identified using International Classification of Diseases, 9th ed. 
(ICD-9) diagnosis codes for sepsis, severe sepsis, and septic shock (785.52; 995.91; 995.92).   
• BMI was derived from the medical record as recorded by the pharmacy rather 
than being calculated from height and weight, due to inconsistently documented height and 
weight. BMI was defined as an index of weight adjusted for height (kg/m2) that indirectly 
estimates body fat.  
• Age was calculated from the date of birth. 
• The date of death was identified through the Social Security Administration Death 
Master File and defined as death from any cause. 
• Biologic sex was self-reported by the individual. 
• Race and ethnicity were self-reported by the individual.   
• WBC value was obtained from a laboratory report.  Severe infection and sepsis 
can result in elevation ranging from 12,000 to 30,000 cells/mm3.  Values > 30,000 were excluded 
since values higher than this level could be resultant from congenital or malignant conditions 
rather than from sepsis (Widick & Winer, 2016). 
• Lactate value was obtained from a laboratory report.  Values in the range of 2 - 4  
mmol/L indicate septic shock (Bakker, 2017; Vellinga et al., 2017). 
• CRP value was obtained from a laboratory report.  Values > 10 mg/L can indicate 
inflammation, and a range of 10-50 mg/L can indicate infection (Kusher et al., 2019).  
Statistical Plan 
A quantitative study using logistic regression was conducted to analyze the relationships 
among the variables and their ability to predict the likelihood of the dichotomous dependent 
variable of mortality at the three-time points described.   
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Descriptive Statistics. The data were examined descriptively and graphically.  For 
continuous variables, distributions were assessed with histograms and outlier box plots, and the 
means and standard errors were calculated and reported in tabular form.  For categorical 
variables, frequencies and percentages were calculated and reported in tabular form.  Further, the 
means with standard deviations and frequencies with percentages are presented for BMI < 30 
(not obese) and ≥ 30 (obese) and pooled to describe the data. 
Logistic Regression Models.  Logistic regression was used to build prediction models 
using the method proposed by Hosmer and Lemeshow (1989).  In this analysis, there are three 
dependent mortality variables defined by time (30 days, 180 days, and one year) for which 
logistic regression was used to assess the effect of BMI on mortality, the effect of demographic 
(age, race, sex) and biologic (CRP, lactate, WBC) covariates on mortality and the interaction of 
BMI and demographic and biologic covariates on mortality.  Thus, the analysis steps that follow 
applied to each of the dependent variables. 
Assumptions for logistic regression include a binary dependent variable, independence 
among the observations, linearity in the logit for continuous predictors, and no multicollinearity 
among the predictors.  Finally, it assumes that the sample size is sufficient as defined by n = 100 
+50i, where i is the number of predictor variables (Bujang et al., 2018).   
Steps to Model Building.  Using the model-building strategy proposed by Hosmer and 
Lemeshow (1989), the first step was to explore associations between each independent variable, 
to include age, race, sex, c-reactive protein, lactate, and white blood cells and mortality using 
simple logistic regression.  Independent variables with p-values < 0.25 made the variable eligible 
for inclusion in a subsequent multiple regression model.  In the second step, a multivariable 
model was formed using all eligible variables from the first step.  Variables with a p-value > 0.05 
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were eliminated from the model one at a time using a backward stepwise approach, with 
the least significant variable being removed first.  In the third step, interactions between the 
remaining main effects deemed of clinical interest were added to the model in the second step. 
The interaction terms of BMI and sepsis type, BMI and age, BMI and sex, BMI and race, BMI 
and CRP, BMI and lactate, and BMI and WBC were entered into each model.  Similar to in the 
second step, a backward stepwise approach was used to remove those interactions with a p-value 
> 0.05.  The resultant model was considered the final predictive model.  Note that this process 
was used three times, one for mortality at 30 days, 180 days and one year. Wald’s test was used 
to assess the contribution of individual predictors in each model and the c-index was used to 
measure goodness of fit.  Data analysis was carried out using JMP Pro version 14.2.0 (64-bit) 
and SAS. 
Results 
Descriptive statistics are presented for the variables of age, sex, race, BMI, CRP, lactate, 
and WBC.  Each predictor variable is summarized with sample sizes, with means, and standard 
deviations (SD) for continuous variables and percentages for categorical variables, see Table 1. 
Age ranged from 18 to 97, (M = 56.56, SD = 16.17). The range of BMI was 14.26 to 84.72 
kg/m2; 65% had a BMI < 30 and 35% had a BMI > 30.  CRP ranged from 0.15 to 0.63 mg/dl.  
Lactate ranged from 0.1 to 5.9 mmol/L. Within the total sample, 52% were black non-Hispanic, 
48% were white non-Hispanic, 44% were female, and 56% were male.  Diagnoses were 21% 
Severe Sepsis, 35% Septic Shock, and 44% Sepsis. WBC results ranged from 0.05 to 29.8 (5,000 
to 29,800 cells/mm3).  
30-Day Mortality.  The overall model goodness of fit was adequate, with a c-index of 
0.726.  In the initial analysis for 30-day mortality, higher levels of lactate were associated with 
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mortality in simple logistic regression. While lower levels of BMI were associated with 
mortality.  Race (p = 0.09), CRP (p = 0.39) and WBC (p = 0.74) were not statistically significant 
and did not meet criteria for inclusion into the full model.  Sex (p =0.35) was not statistically 
significant but was retained in the full model due to biological importance.  
The final 30-day logistic regression model included sepsis type, age, lactate, BMI, and 
sex (n = 1,554), see Table 2B.  Odds ratios with 95% confidence intervals are presented for each 
variable, see Table 2C.  For every 5 unit increase in BMI, the odds of survival are 0.92 (95% CI: 
0.85, 0.99) times lower, or for every 5 unit decrease in BMI, the odds of death are lower.  Age, 
lactate, and sepsis type were associated with increased odds of death.  For every five year 
increase in age, the odds of death are 1.14 times higher (95% CI: 1.09, 1.19). We found 3.56 
times higher odds of death for a patient with septic shock versus sepsis and 1.63 times greater 
odds of death for a patient with severe sepsis versus sepsis at 30 days.  For every one-unit 
increase in lactate, the odds of death were 1.34 times higher.  
180-Day Mortality.  The c-index was 0.74, indicating good goodness of fit. Simple 
logistic regression analysis for each independent variable and the dependent variable of 180-day 
mortality indicated that age, sepsis type, WBC, lactate, race, and BMI held a statistically 
significant association.  These significant variables and sex (p = 0.29), which was not significant 
but was retained due to biologic importance, were eligible for entry into the full logistic 
regression model.  Backward stepwise regression was used to eliminate variables one at a time 
for significance > 0.05, except for sex, which was retained in the model despite lack of 
significance due to biological importance.  The final 180-day model included age, lactate, WBC, 
sex, and the interaction term of BMI and sepsis type (n = 3,720) see Table 2B.  Odds ratios with 
95% confidence intervals are presented for each variable, see Table 2C.  For every five year 
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increase in age, the odds of death are 1.16 times (95% CI: (1.14, 1.19) higher.  For every 10 unit 
increase in WBC, the odds ratio was 0.82 times (95% CI: 0.74, 0.90) lower.  Males had a slightly 
higher odds of death than females at this time point.  The main effect of BMI was statistically 
significant, indicating that higher levels of BMI were associated with lower mortality (p 
<0.0001).  However, the interaction term of BMI and septic shock was also significant, 
demonstrating that in the context of septic shock increasing BMI was associated with higher 
mortality (p = 0.0006).  
1-Year Mortality.  The c-index was 0.73, indicating good goodness of fit. Initial analysis 
at 1-year (365 days) indicated that age, sepsis type, WBC, lactate, race, and BMI were significant 
in simple logistic regression.  Backward stepwise regression was performed, and the final model 
included age, sex, WBC, and the interaction term of BMI and sepsis type (n= 3,720) see Table 
2B.  Odds ratios with 95% confidence intervals are presented for each variable, see Table 2C.  
For every 10 unit increase in WBC, the odds of death were 0.74 (95% CI: 0.67, 0.82).  For every 
five year increase in age, the odds of death were 1.22 (95% CI: 1.19, 1.24).  As with the other 
time points, sex was not statistically significant. The main effect of BMI was statistically 
significant, indicating that higher levels of BMI were associated with lower mortality (p 
<0.0001).  However, the interaction term of BMI and septic shock was also significant, 
demonstrating that in the context of septic shock increasing BMI was associated with higher 
mortality (p = 0.001), and in the context of severe sepsis increasing BMI was associated with 
higher mortality (p = 0.041).   
Discussion 
In this study, we aimed to gain insight into the relationship between BMI, demographic, 
and biologic factors with sepsis mortality at three-time points using data over a ten year period 
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from a large academic medical center.  Consistent with other studies, we found that increasing 
BMI was protective in the context of sepsis at 30-days. We hypothesize that the chronic 
inflammation observed in obesity causes an attenuated response in sepsis, resulting in lower 
mortality.  However, this effect did not continue to hold constant at 180-days or 1 year after 
diagnosis.  In our sample, we used BMI as recorded in an electronic health record to define 
obesity. We also limited our analysis to patients with a BMI > 14 and < 90 kg/m2.  The small 
number of patients at the extreme ranges of BMI offered insufficient statistical power to draw 
meaningful conclusions.  Therefore, results cannot be related to individuals outside of this BMI 
range.   
These results were corroborated by two recent large retrospective studies and one 
prospective study.  Mewes et al. (2019) examined obesity in septic shock at 90 days using a 
prospective cohort (N=352) where 24% were obese compared to 75% non-obese patients and 
found lower 90-day mortality (31% vs. 43%; p = 0.0436) in obese patients.  Li and colleagues 
(2019) found that obese patients showed a survival advantage at 30 days.  However, the benefit 
was not significant at the end of one year for both severe sepsis and septic shock subsets in a 
sample (n = 5,563) drawn from the Multiparameter Intelligent Monitoring in Intensive Care 
(MIMIC-III) database (Li et al., 2019).  Pepper et al. (2019) used the Cerner electronic health 
record database to garner a cohort of 55,038 adults hospitalized with sepsis and found that 30-
day mortality was lower in overweight and obese patients compared with those with normal 
weight BMIs.  The distribution of BMI across categories was similar between our study and the 
two recent retrospective studies while the prospective study categorized individuals as "obese" or  
"not obese."  Given the similarity between sample characteristics, these results may represent the 
association between BMI and mortality adequately for similar populations.  Although obesity 
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may be protective in the context of sepsis in the short-term, future prospective studies that follow 
patients over the long-term are needed to elucidate phenotypes of sepsis survivors. 
The rationale for the protective effect of obesity has not been fully described. 
Physiologically, adipose tissue has several functions, including inflammation and immunity.  
One proposed theory is that the chronic inflammation of obesity creates a type of resistance to 
further inflammatory insults (Robinson, Swift-Scanlan, & Salyer, 2020).  In other words, when 
there is a state of chronic inflammation, an acute insult such as sepsis may not have a less 
harmful effect on obese versus non-obese individuals (Robinson, Swift-Scanlan, Salyer, et al., 
2020).  Abbate et al. (2016) expanded upon this concept and proposed that obese adults may be 
chronically immune stimulated, which might improve pathogen clearance and reduce mortality.   
 While BMI is accepted internationally as the standard method for identifying obesity 
(Engin, 2017), there are limitations to the use of BMI to estimate adiposity.  BMI is an index of 
weight adjusted for height that indirectly estimates body fat.  Overall, body composition of fat 
and muscle and distribution of body weight are not accounted for in this metric, which does not 
take into account sex and racial differences, age differences, or waist circumference 
(Christopher, 2015; Vlassopoulos et al., 2014).  Individuals with varying clinical and 
biochemical characteristics can be categorized similarly, regardless of emerging evidence of 
obesity phenotypes (Vecchié et al., 2018).  Methods that better quantify adiposity, such as 
measuring waist circumference and waist-to-hip ratio, are valid, low-cost methods that could be 
considered for inclusion in future studies.   
 BMI and Sepsis Severity.  It has been reported that sepsis has a high risk of death, 10-
30%, and that increases to greater than 40% for septic shock (Karampela et al., 2019).  We found 
that BMI and sepsis severity was significantly associated with mortality at 6-months and 1-year 
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after sepsis.  There was a stepwise increase in odds of death for every 5 unit increase in BMI for 
sepsis, severe sepsis, and septic shock.  Given our results, increasing BMI was not protective per 
category of sepsis severity.  Perhaps the biological processes underlying obesity and sepsis 
severity may be more complicated than can be explained in this statistical model that does not 
take into account confounding factors such as chronic comorbidities.  For example, obese people 
suffer from chronic diseases that can increase mortality, such as type 2 diabetes, chronic 
obstructive pulmonary disease (Papadimitriou-Olivgeris et al., 2016), hypertension, heart failure, 
and renal failure (Nguyen et al., 2016).  Future studies that control for comorbidities is needed. 
 Criteria for diagnosis and algorithms for sepsis treatment have evolved over time and still 
may differ between medical centers (Pepper et al., 2016).  Our study was unable to examine time 
to antibiotic therapy, types of microbe and cause of infection, or sepsis treatment algorithm.  
Antibiotic administration after the recommended 6-hour window has been associated with sepsis 
mortality, with up to a 7.6% decrease in sepsis survival for every one hour of delay (Sherwin et 
al., 2017).  Skin and soft tissue infections, which respond to well to treatment, are more common 
causes of sepsis in those with higher BMI versus normal BMI  (Arabi et al., 2013; Wacharasint 
et al., 2013).  Consensus criteria for sepsis diagnosis have changed three times in the past two 
decades (Bone et al., 1992; Levy et al., 2003; Singer et al., 2016), owing to advancing science, 
and associated changes in clinical practice guidelines which have evolved, resulting in better 
outcomes overall (Coopersmith et al., 2018).  
Sepsis and Demographic Contributors 
 Sepsis and age.  We examined several models by logistic regression, including age as a 
predictor variable.  We found that there was only a minor difference in odds of mortality at 30 
days and 180 days, but that as time went on, the odds of death increased.  For every 5 year 
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increase in age the odds of death were 1.15 (95% CI: 1.09, 1.19) at 30 days, 1.16 (95% CI: 1.14, 
1.19) at 180 days, and 1.22 (95% CI: 1.19, 1.24) at 365 days.  The results of our study were 
similar to those found by other researchers (Herrán-Monge et al., 2019; Li et al., 2019; Pepper et 
al., 2019).  As the population of the United States is changing toward a large elderly population, 
understanding how conditions such as sepsis are affected by age is important.  Particularly, since 
of those that survive sepsis, new cognitive and functional limitations may occur among those 
with no previous limitations and those who had mild to moderate limitations before sepsis 
(Iwashyna et al., 2010).  As improved early diagnosis and treatment occurs, and more people 
survive sepsis, there is an increased need to understand the long-term impact.  
 Sepsis and sex.  Biologic sex and the role of sex in sepsis outcomes is complicated due to 
physiologic differences between males and females and because of potential sex-related social 
and environmental differences.  While our study did not show sexual dimorphism regarding 
sepsis mortality, other studies have demonstrated this phenomenon (Nachtigall et al., 2011). The 
role of sex steroid hormones is thought to influence the expression and outcome of many 
diseases, such as autoimmune disorders, which are about 9-times more common in females as 
compared with males (Weniger et al., 2015).  Estrogens have pro- and anti-inflammatory 
properties, while androgens are primarily anti-inflammatory (Klein, 2000).  The enhanced 
immune response during the proestrus cycle in females has been found to be protective against 
developing sepsis and for the survival of sepsis (Mayr et al., 2014; Weniger et al., 2015).  
Whereas in males, testosterone has an integral role in immune depression after trauma and sepsis 
(Schröder et al., 1998).  Beyond biological contributors, sex is also a social construct.  Social and 
environmental factors and chronic disease burden may contribute to the increased susceptibility 
of sepsis in males (Mayr et al., 2014).  It is unclear if females have a survival advantage, if there 
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is under-diagnosis of sepsis in females, or if there are differences in healthcare access and 
delivery (Fowler et al., 2009; Schröder et al., 1998). 
Sepsis and race.  Race represents genetic, social, and environmental factors that 
influence health, such as access to healthcare, quality of care received, and environmental 
exposures (Shankar-Hari & Rubenfeld, 2018).  As opposed to epidemiologic studies that 
reported a higher risk of mortality for black versus white patients (Barnato et al., 2008; Mayr et 
al., 2014; Sandoval & Chang, 2016), our study showed no association between race and sepsis 
mortality.  However, a recent study that used data solely from academic medical centers reported 
that blacks had lower mortality than whites (OR 0.85; 95 % CI: 0.84–0.86) (Chaudhary et al., 
2018). Conflicting data such as this reflects the need for further research to explicate the 
relationship between race and sepsis mortality. 
Social and environmental factors play important roles in healthcare access and disease 
mortality.  Our study underscores population characteristics that drive regional sepsis outcomes 
rather than national norms.  The Richmond metropolitan area is one of the three most densely 
populated areas of Virginia.  Rather than mirroring the racial distribution of the population of 
Virginia, which is 71.5% white and 20.7% black, the racial distribution of Richmond is 
approximately 50.6% black and 45.9% white (Virginia Department of Health [VDH], 2020). 
However, the catchment area of the academic medical center is regional, reflecting relatively 
lower percentages of uninsured individuals and moderate percentages of poverty among 
individuals the surrounding counties. 
Sepsis and Biologic Contributors 
Sepsis and lactate.  Hyperlactatemia is an indicator of septic shock and a predictor of in-
hospital mortality (Singer et al., 2016).  It is thought that anaerobic metabolism and oxidative 
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stress, hallmarks of septic shock, contribute to hyperlactatemia (Duman et al., 2016).  However, 
few studies describe an association between hyperlactatemia and late mortality from sepsis.  
Villar and colleagues (2019) examined the prognostic ability of lactate to predict mortality at 30-
day and 1-year and found an odds of 1.5 higher for 30-day mortality (95% CI: 1.1-2.1) and an 
odds of 1.3 for 1-year mortality (95% CI: 1.1-1.6).  Lower lactate levels were associated with 
long-term mortality, and higher lactate levels were associated with short-term mortality (Villar et 
al., 2019).  Our study confirmed that hyperlactatemia is associated with short-term mortality, but 
we were unable to see the effect on late mortality.   
Age was not significantly associated with lactate in our models that examined late 
mortality.  However, when the prognostic value of lactate in the elderly (> 65 years of age) for 
28-day mortality was investigated researchers found that lactate was significantly lower in 
elderly septic patients (5.5 ± 4.9) versus those under age 65 (6.6 ± 6.7, p = 0.001) (Cheng et al., 
2018).  The physiologic changes that occur with aging may be responsible for this difference. In 
our sample age was normally distributed between 18 and 97, but 31% of the sample was age 65 
or older, perhaps affecting the impact of lactate on mortality at the two later time points.  
Sepsis and WBC.  White blood cells are described as the biomarker most often used 
along with clinical parameters to diagnose sepsis (Shukeri et al., 2018), but WBCs have low 
sensitivity and specificity for sepsis (Gucyetmez & Atalan, 2016).  We found that for 30-day 
mortality, WBCs were not significantly associated with sepsis mortality.  One reason for this 
may be that leukocytosis is a normal physiologic reaction that is mounted to combat infection. 
Therefore, leukocytosis may indicate a robust immune system and a superior ability to fight off 
infection in the short-term.  In our sample, we found that for every 10 unit increase in WBC, the 
odds of death were 0.82 (95% CI: 0.74, 0.90) times lower for 180-day mortality and 0.74 (95% 
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CI: 0.67, 0.82) times lower for 365-day mortality.  This could be an indication of less severe 
sepsis in our population, as lower levels of WBC may be associated with less severe infection, 
which may translate into lower mortality. 
Sepsis and CRP. As an acute-phase reactive protein, CRP is elevated in states of 
inflammation.  In chronic inflammation, such as obesity, the elevation is mild, but in an acute 
condition such as sepsis, the elevation is marked (Hribal et al., 2014).  CRP has been studied as a 
successful prognostic indicator in sepsis (Gradel et al., 2013; Mustafić et al., 2018), yet in our 
research, we found no association between CRP and mortality at any time point.  Several factors 
could influence the level of CRP, including co-morbidities, sepsis recurrence, and obesity.  Our 
findings may reflect our decision to use only the first admission date for sepsis as an inclusion 
criterion and to use only one value of CRP rather than examining values serially. Additionally, in 
our data there were relatively few (n=441) observations with a CRP value recorded. 
Biomarkers other than CRP may better assess for obesity-related protection in sepsis.  CRP is 
chronically elevated in obesity, along with other biomarkers such as interleukin-6 (IL-6) and 
leptin, due to heightened endocrine and immunologic activity when there is excess adipose tissue 
(Abdullah et al., 2009; Florez et al., 2006).  Increased adiposity causes dysregulation resulting in 
the up-regulation of CRP, IL-6, tumor necrosis factor-α (TNF-α), and leptin along with the 
simultaneous downregulation of adiponectin.  Leptin and adiponectin are opposing adipokines; 
leptin is pro-inflammatory and adiponectin is anti-inflammatory.  It is leptin’s involvement in 
immunity and inflammation, particularly related to the activation of immune cells and cytokine 
expression that makes it an attractive biomarker to demonstrate protection from 
sepsis (Yousef et al., 2010).  Low leptin and high IL-6 levels have been observed in 
sepsis patients with unfavorable outcomes (Bornstein et al., 1998), and animal models have 
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shown that hyperleptinemia was associated with better sepsis outcomes (Negrin et al., 2017; 
Siegl et al., 2014).  As there was little to no IL-6, TNF-α, or leptin biomarker measures in our 
retrospective dataset, we recommend prospective studies that include a series of biomarkers, 
including leptin, to test associations with sepsis outcomes and mortality.  
Long-Term Outcomes 
Sepsis survivors often experience morbidity, destabilizing health, and increased 
healthcare utilization, hospital readmission, and even mortality (Jones et al., 2015; Mayr et al., 
2014).  The risk of long-term mortality may be overshadowed by the characteristics of acute 
illness, which may not be representative of late mortality (Shankar-Hari et al., 2019).  Recently, 
Demerle et al. (2017) reported that two-thirds of rehospitalizations after sepsis were due to 
infection and that among those readmitted for sepsis within 90 days, the mortality rate was 
21.2% versus 10.5% for those readmitted for a different diagnosis (p = 0.002).  Among those 
who survive sepsis, many experience persistent residual symptoms of physical, psychological, 
cognitive, and functional frailty (Gardner et al., 2019; Iwashyna & Netzer, 2012; Winters et al., 
2010), such as fatigue, muscle weakness, difficulty swallowing, difficulty concentrating, poor 
memory, sadness, and anxiety (Prescott & Angus, 2018).   
In addition to the physical deterioration seen after sepsis, survivors of sepsis experience lower 
quality of life for up one and half years afterward.  In the Finnsepsis study, researchers found 
that patients recover slowly from severe sepsis and have a low quality of life when compared 
with controls, and had 1.5 times higher mortality at two years than in-hospital (Karlsson et al., 
2009).  A Chinese prospective multi-center study showed that severe sepsis 
survivors had impaired quality of life at up to 6 years after hospital discharge (Zhang et 
al., 2013).  Secondary analysis of the large-scale ACCESS and PROWESS-SHOCK trials 
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showed that about one-third of 6-month survivors reported poor quality of life, problems with 
mobility and self-care, and most required residency at a rehabilitation center, nursing home, or 
acute facility (Yende et al., 2016).  Fears of medical setbacks in the weeks to months after sepsis 
have also been documented (Prescott & Angus, 2018).  Sepsis is proving to be more than an 
acute syndrome; it has chronic consequences that can result in a declining physical function and 
quality of life measures over time (Winters et al., 2010). 
Limitations 
The use of retrospective medical record data is helpful for examining a large population 
over a long period of time.  However, there are several limitations.  First, the study population is 
drawn from a single academic medical center, so it may not generalize to community hospitals or 
areas with different sociogeographical characteristics.  This study used all-cause mortality rather 
than disease specific mortality due to limitations of available data.  Our reliance upon electronic 
health records holds a potential for the inaccuracy of information entered into the medical record 
and may reflect differences in diagnostic and treatment protocols over the ten year time period.  
In particular, the availability of laboratory data for newly recognized and investigative 
biomarkers such as leptin was not available in this sample.  There were few observations with 
CRP values documented, which may have impacted results. The sample size was reduced by 
nearly half due to lack of BMI documentation in the dataset; height and weight were 
inconsistently available and BMI documented by pharmacy was all that was available.  
Additionally, using ICD-9 codes to identify the presence of sepsis may not accurately account 
for all cases of sepsis, and this method lacks granular detail about the timing of sepsis.   
Using only the first admission date for sepsis promoted independence between 
observations but may not adequately capture the increasing magnitude of illness that can occur 
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with sepsis recurrence.  Lastly, our data did not include co-morbidities, which may be an 
essential missing piece that, if present, would help to discriminate between sepsis phenotypes. 
Conclusion 
Sepsis is a serious health concern resulting in high rates of mortality.  Our study 
demonstrates that increasing BMI is associated with reduced sepsis mortality at 30 days, but not 
at longer time points.  Overall, after taking into account the strengths and limitations of this study 
design, it appears that the "obesity paradox" may exist at 30 days, but the protective effect does 
not extend beyond that time point.  Our findings regarding demographic characteristics and 
biologic contributors were consistent with other published reports.  Given the importance of 
long-term sepsis sequelae and the increasing rates of obesity, research that characterizes the 
phenotype of sepsis survivors based on BMI is needed to identify and meet the needs of this 
growing population.   
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Figure 1:  Study flow diagram. 
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Figure 2: For 180 day mortality, the interaction terms of sepsis type and BMI is reported to 
further demonstrate the relationship between these predictor variables. For Sepsis versus 
Severe Sepsis there is little change as BMI increases. For Sepsis versus Sepsis Shock as BMI 
increases there are increased odds of mortality; for a BMI of 15 the OR=2.64 (CI: 1.92, 3.61) 
while for a BMI of 40 the OR = 6.80 (CI: 4.92, 9.39). 
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Figure 3: For 1-year mortality, the interaction terms of sepsis type and BMI is reported to 
further demonstrate the relationship between these predictor variables. For Sepsis versus 
Severe Sepsis and for Severe Sepsis versus Septic Shock there is little change as BMI increases. 
For Sepsis versus Sepsis Shock as BMI increases there are increased odds of mortality; for a 
BMI of 15 the OR=2.34 (CI: 1.73, 3.18) while for a BMI of 40 the OR = 5.52 (CI: 4.08, 7.47). 
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Table 1: Descriptive Statistics of the  Variables in the Sample for this Study. 
 
 N Means SD Percentage Missing 
Age 3832 56.56 16.71  7 
BMI 3839 28.63 8.8  0 
CRP 441 15.42 33.4  3398 
Lactate 1556 1.95 1.92  2284 
Race 3839   100% 0 
Black, Non-Hispanic 1993   52% 0 
White, Non-Hispanic 1846   48% 0 
Sepsis Type 3839   100% 0 
Sepsis 1696   44% 
0 
Severe Sepsis 789   21% 
0 
Septic Shock 1354   35% 
0 
Sex 3839   100% 
0 
Female 1698   44% 
0 
 Male 2141   56% 
0 
*Cells are empty when the variable is not described by the method indicated by the column 
header (i.e.: continuous variable are not described by percentages; categorical variables are not 
described by means and SD).  
  
 
Table 2:  Logistic regression modeling of predictors at three time points of mortality. Bivariate analysis identified predictors 
eligible for testing in subsequent multivariable logistic regression models; those with a p value of value of < 0.25, see Table 2A.  
Eligible predictors for the multivariable models were used to generate models through backward stepwise logistic regression, along 
with the interaction terms of each predictor variable and BMI (i.e.: BMI and sepsis type), see Table 2B. Odds ratios and confidence 
intervals for each significant predictor, along with the significant interaction term of sepsis type and BMI are described with odds 
ratios and confidence intervals, see Table 2C. The interaction terms of sepsis type at a BMI of 25 (normal weight) is reported to 
further demonstrate the relationship between these predictor variables on mortality at 180 days and 365 days 
 
Predictor N 2A: Bivariate Models 2B: Final Multivariable Models 
  
30 Days 
180 
Days 
365 
Days 
30 Days 
(n=1554) 
180 Days 
(n=3720) 
365 Days 
(n=3720) 
    p-value p-value p-value p-value p-value p-value 
CRP 441 0.3922 0.0673 0.0256    
Race 3839 0.0873 0.0342 0.0204    
Age 3832 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Sex 3839 0.3553 0.2907 0.9629 0.7764 0.2852 0.7724 
Lactate 1556 <0.0001 <0.0001 <0.0001 <0.0001   
Sepsis Type 3839 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
BMI 3839 <0.0001 <0.0001 <0.0001 0.0212 <0.0001 <0.0001 
WBC 3726 0.7465 0.0012 <0.0001  0.0064 <0.0001 
BMI*Sepsis Type - - -  -  0.0023  0.0044 
 Parameter         2C: Odds Ratio and 95% Confidence Intervals 
 
     30 Days 180 Days  365 Days  
Age, per 5 year increase       1.14 (1.09, 1.19) 1.16 (1.14, 1.19) 1.22 (1.19, 1.24) 
Sex, Female      1.03 (0.97, 0.99) 0.92 (0.79, 1.07) 1.02 (0.88, 1.18) 
Lactate, per 1 unit increase     1.34 (1.22, 1.47)   
Sepsis vs. Severe Sepsis     1.63 (1.12, 2.38)   
Severe Sepsis vs. Septic Shock    2.18 (1.60, 2.98)   
Sepsis vs. Septic Shock    3.56 (2.60, 4.90)   
BMI, per 5 unit increase     0.92 (0.85, 0.99)   
Sepsis vs. Severe Sepsis at BMI=25     1.35 (1.08, 1.67) 1.28 (1.04, 1.58) 
132 
 
Severe Sepsis vs. Septic Shock at 
BMI=25     2.86 (2.31, 3.54) 2.57 (2.08, 3.17) 
Sepsis vs. Septic Shock at BMI-25    3.85 (3.23, 4.59) 3.30 (2.78, 3.91) 
WBC, per 10 unit increase      0.82 (0.74, 0.90) 0.74 (0.67, 0.82) 
*The symbol “- ”represents an untested interaction term in bivariate testing. Empty cells within the table represent variables that were 
not found to be significant and were excluded from analysis. 
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Concluding Narrative 
 This dissertation shed light on some of the contributing factors that influence mortality at 
30 days, 60 days, and 1 year post-sepsis diagnosis.  The systematic review of the literature in 
Chapter One described the current state of knowledge about the “obesity paradox” e.g., the 
association between obesity and sepsis mortality. A gap in the literature was identified, where 
long term sepsis outcomes after 30 days had not yet been described. Chapter Two outlines a 
conceptual model that links the main concepts of inflammation, sepsis and obesity through 
pathophysiologic mechanisms, and describes how to use the model for testing relationships 
between antecedents, the main concepts, and multiple sepsis outcomes. This conceptual model 
was the framework for the dissertation proposal in Chapter Three and the results “manuscript 
ready” study presented in Chapter Four. We used a large dataset that spanned a 10 year time 
frame to characterize a population of individuals diagnosed with sepsis at a large academic 
medical center. Our findings supported previous studies of short-term post-sepsis mortality, but 
highlights that there is more research needed to understand obesity and longer term sepsis 
mortality. The lack of available laboratory data on specific novel biomarkers is a limitation of 
this study that comes from using a secondary, retrospective, clinical dataset. 
 While this initial study did not show a connection between obesity and long-term sepsis 
mortality, there is literature that suggests this is still an area worthy of research. This researcher 
plans to seek funding to conduct a prospective study that follows patients from the time of 
diagnosis to one year after diagnosis. A strength of this approach is that comorbidities can be 
identified and controlled for, adiposity related metrics to augment body mass index can be 
included and testing of specific novel biomarkers can be incorporated. There is ample 
opportunity for research in the area of obesity and sepsis outcomes.  Of patients that survive the 
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initial sepsis insult, long-term cognitive, emotional, and physical frailty is an emerging concern. 
Considering the aging population, research that aims to improve the lives of patients post sepsis 
is highly needed. 
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